Autosomal Recessive Nonsyndromic Hearing Loss 77

👪

Inheritance

1

Autosomal recessive HP:0000007

Biallelic LOXHD1 variants. Reported as homozygous in consanguineous families and as compound heterozygous elsewhere.

Autosomal recessive inheritance

Show evidence (3 references)

PMID:19732867 SUPPORT Human Clinical

"we screened DNA from human families segregating deafness and identified a mutation in LOXHD1, which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL)"

Establishes the recessive inheritance and names the locus.

PMID:29676012 SUPPORT Human Clinical

"All variants were detected in a compound heterozygous state and all segregated with HI in the families."

The Dutch cohort directly supports compound heterozygous inheritance.

url:https://www.ncbi.nlm.nih.gov/books/NBK1434/ SUPPORT Other

"If both parents are known to be ... heterozygous ... autosomal recessive ... hearing loss-related ... pathogenic variant ... has at conception a 25% chance of having hearing loss"

General Mendelian counseling applies to confirmed biallelic DFNB77 when the parental carrier genotypes are established.

?

Discussions and Knowledge Gaps

2

Which allele-specific, splicing, genetic or environmental factors explain variation in DFNB77 onset and course?

KNOWLEDGE GAP OPEN dfnb77_no_genotype_phenotype_correlation

Attached to

genetic#LOXHD1 phenotypes#Progressive Sensorineural Hearing Impairment progression#Onset

The Dutch and Japanese cohorts did not establish a simple relationship between variant class or position and severity or progression. Their limited sample sizes, follow-up differences, uncertain variants and heterogeneous compound genotypes constrain those negative findings. Intrafamilial variation is documented, but no specific human modifier has been established by these studies. Nonsense-associated alternative splicing was proposed to attenuate a mouse allele and is a candidate mechanism to test in human variants, not a demonstrated explanation for human variability.

Proposed experiments

Modifier and noise-exposure study in the Japanese c.4212+1G>A cohort

exp_dfnb77_modifier_and_exposure_study

Study longitudinal hearing in individuals carrying c.4212+1G>A while explicitly accounting for the second allele, phase, age, treatment and follow-up. Test transcript consequences, candidate genetic modifiers and measured exposures using adequate comparison groups. Sharing one allele does not hold the whole genotype constant.

Would support

genetic#LOXHD1

Supporting outcome

Progression rate tracks a modifier locus or a measured exposure, converting an unexplained variance into a counselling-relevant and potentially modifiable factor.

Refuting outcome

No association would limit the tested hypotheses at the available power; it would not establish stochastic causation or the impossibility of prognosis.

Show evidence (2 references)

PMID:29676012 SUPPORT Human Clinical

"a clear correlation between the type or location of the variant and the severity or progression of HI could not be established. We hypothesize that environmental factors or genetic modifiers are responsible for phenotypic differences."

The cohort found no clear correlation; environmental and genetic modifiers remain hypotheses.

PMID:31547530 SUPPORT Human Clinical

"Patients with LOXHD1 variations mostly showed early onset hearing loss and presented different progression rates. We speculated that the varying severities and progression rates of hearing loss are the result of environmental and/or other genetic factors."

The Japanese variant cohort also showed variable progression, but did not test specific modifiers.

Which LOXHD1 interfaces and lipid interactions stabilize the TMC1-tip-link connection, and can restoring that connection recover mature hair-cell function?

KNOWLEDGE GAP OPEN dfnb77_how_loxhd1_gates_transduction

Attached to

pathophysiology#LOXHD1 Loss of Function in Stereocilia pathophysiology#Reduced Hair-Cell Mechanotransduction

The 2024 deletion and tagged-protein experiments establish that LOXHD1 maintains TMC1 near the lower tip-link insertion. Earlier preservation of Harmonin and LHFPL5 did not establish normal localization of every mechanotransduction component. Co-immunoprecipitation supports associations with TMC1, CIB2, LHFPL5 and PCDH15, but exact direct-binding interfaces and the contribution of membrane lipids remain unresolved. The p.Val1892Phe lipid-affinity proposal remains computational. Persistence of some mislocalized TMC1 motivates rescue experiments; a therapeutic window and effective gene replacement have not been demonstrated by these localization studies.

Proposed experiments

Map LOXHD1 interaction interfaces and test functional rescue

exp_dfnb77_loxhd1_interactome_and_lipid_binding

Map individual PLAT-repeat protein and lipid interactions, then compare wild-type and disease-associated constructs in biochemical assays and Loxhd1-null hair cells. Measure TMC1 tip localization, MET currents and bundle survival after timed re-expression.

Would support

pathophysiology#Reduced Hair-Cell Mechanotransduction

Supporting outcome

Restored LOXHD1-dependent TMC1 positioning is accompanied by recovery of mechanotransduction, identifying a functional interaction and an experimentally supported rescue interval.

Refuting outcome

Restoring localization fails to restore currents, or particular binding-deficient constructs retain function, limiting the proposed mechanism. Negative results require adequate expression and assay sensitivity before excluding a role.

Show evidence (2 references)

PMID:39256406 SUPPORT Other

"The interaction between LOXHD1 and PCDH15 could occur through direct binding, indirect mediation via LHFPL5, or a combination of both mechanisms."

The interaction topology remains a stated limitation of the proposed stabilizing model.

PMID:26973026 SUPPORT Computational

"Molecular modeling predicted that distorted structure of the PLAT domain in the p.V1892F mutant could lead to decreased affinity of the protein to lipid membrane resulting in hair cell dysfunction."

The one LOXHD1-specific prediction of a lipid-binding role, which is why this gap is described as lacking an experimental test rather than lacking a hypothesis. Graded COMPUTATIONAL, and the authors' hedge "could lead to" is kept in the quote.

⚙

Pathophysiology

9

LOXHD1 Loss of Function in Stereocilia

Biallelic pathogenic LOXHD1 variants impair a stereociliary protein containing up to fifteen PLAT repeats. The molecular consequence is allele dependent: missense variants need not remove the protein, and nonsense-associated alternative splicing can preserve part of its coding sequence in a mouse model. Epitope-tagged mouse LOXHD1 is enriched at the tips of the shorter, transducing stereocilia. Earlier staining along the stereociliary membrane used an antibody whose specificity could not be confirmed with a complete null control.

cochlear inner hair cell CL:0000589 cochlear outer hair cell CL:0000601

LOXHD1 hgnc:26521

Genetic context allele_type: VARIANT variant_origin: GERMLINE functional_impact_category: LOSS_OF_FUNCTION

stereocilium GO:0032420

Downstream

Reduced Stereociliary TMC1 Abundance

TMC1 Mislocalization from Tip-Link Insertion Sites

Show evidence (4 references)

PMID:19732867 SUPPORT Model Organism

"LOXHD1 consists entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains and is expressed along the membrane of mature hair cell stereocilia."

The protein's composition and its subcellular location, which together define this node.

PMID:33707295 SUPPORT INDIRECT Model Organism

"LOXHD1 consists of 15 polycystin lipoxygenase α-toxin (PLAT) repeats, which in other proteins can bind lipids and proteins."

The repeat count and the functional class of the repeats. INDIRECT because the inference that LOXHD1's repeats bind lipids and proteins is carried over from other PLAT-domain proteins rather than demonstrated for LOXHD1 - the authors' own hedge "in other proteins" is kept in the quote.

PMID:39256406 SUPPORT Model Organism

"We infer from these results that LOXHD1 proteins localized preferentially at the tips of rows 2 and 3, in the same subcellular domain as the MET channel complexes and where the lower part of the tip link inserts into the stereocilia membrane."

HA-tagged knock-in localization refines the earlier membrane-wide antibody pattern.

+ 1 more reference

Reduced Stereociliary TMC1 Abundance

Loss of LOXHD1 reduces the number of stereocilia retaining TMC1, with marked depletion from the shortest row. Initial TMC1 entry into stereocilia still occurs, distinguishing defective maintenance from complete failure of initial delivery. TMC2 tip localization is preserved, LHFPL5 remains localized, and TMIE is partly reduced. CIB2 immunostaining appeared maintained, but antibody background limited precise assessment.

cochlear inner hair cell CL:0000589 cochlear outer hair cell CL:0000601

stereocilium GO:0032420

Downstream

Reduced Hair-Cell Mechanotransduction

Show evidence (3 references)

PMID:39256406 SUPPORT Model Organism

"First, the quantities of TMC1 molecules were progressively reduced in stereocilia, suggesting that LOXHD1 is not indispensable for the initial presence of TMC1 in the stereocilia"

Localization measurements in the complete deletion model support a maintenance defect rather than an absolute entry requirement.

PMID:39256406 SUPPORT Model Organism

"Therefore, the absence of LOXHD1 had no effect on TMC2 hair bundle row 2 tip localization or expression time."

The TMC2 result helps explain residual early mechanotransduction.

PMID:39256406 SUPPORT Model Organism

"we could not determine with accuracy if CIB2 was affected by LOXHD1’s absence."

The authors explicitly qualify their CIB2 localization result.

TMC1 Mislocalization from Tip-Link Insertion Sites

Remaining TMC1 molecules progressively redistribute away from the lower tip-link insertion along stereociliary shafts. This spatial separation limits transmission of sound-induced forces to the channels. LOXHD1 co-immunoprecipitates with TMC1, CIB2, LHFPL5 and PCDH15-CD2 in heterologous cells, but not with TMC2 or TMIE in the tested assays. These associations and mouse localization support a stabilizing connection; they do not establish the exact direct-binding topology or show that every human variant disrupts the same interaction.

cochlear inner hair cell CL:0000589 cochlear outer hair cell CL:0000601

stereocilium GO:0032420

Animal models

Loxhd1 complete-deletion mouse Mouse measures Large-scale deletion establishes that LOXHD1 maintains TMC1 at the lower tip-link insertion. Remaining TMC1 redistributes along stereociliary shafts, while TMC2 localization is preserved. Inner-hair-cell currents are already reduced at P7 and become more severely impaired at P11.

Downstream

Reduced Hair-Cell Mechanotransduction

BAIAP2L2 Mislocalization

Show evidence (3 references)

PMID:39256406 SUPPORT Model Organism

"LOXHD1 is also critical for maintenance of TMC1 within the first 100 nm of the row 2 tips, where the tip links insert and where the mechanical stimuli are received."

SUB-immunogold-SEM mapped endogenous tagged TMC1 relative to the insertion site in mouse hair cells.

PMID:39256406 SUPPORT In Vitro

"These experiments demonstrate that LOXHD1 interacts selectively in vitro with TMC1 but not with TMC2."

HEK293T co-immunoprecipitation distinguishes the paralogues under the tested conditions.

PMID:39256406 SUPPORT In Vitro

"LOXHD1 interacts selectively with three of the five known MET channel complex proteins TMC1, CIB2, and LHFPL5 plus the lower-tip link protein PCDH15"

Co-immunoprecipitation supports association with these components; direct molecular contacts remain incompletely resolved.

Reduced Hair-Cell Mechanotransduction

Mechanically evoked receptor currents decline in LOXHD1-mutant cochlear hair cells before gross bundle disruption. PLAT10 missense and targeted truncating mouse alleles retain near-control currents at P7 but show severe reduction at P11, with unchanged measured residual-current kinetics at P9. A complete Loxhd1 deletion already reduces currents at P7 and leaves small residual currents at P11. Tip links and selected tip-link proteins can remain present despite TMC1 mislocalization; their presence does not demonstrate an intact channel complex. Human onset and progression cannot be inferred directly from these postnatal mouse time points.

cochlear inner hair cell CL:0000589 cochlear outer hair cell CL:0000601

mechanotransduction in cochlear hair cells GO:0050910 ↓ DECREASED

stereocilium bundle GO:0032421

Animal models

Loxhd1 PLAT10 samba and T1308X mouse comparison Mouse measures Direct measurements show near-normal first-week inner-hair-cell mechanotransduction currents followed by severe impairment at P11. Gross bundle organization and tip links are preserved at these ages, despite modest shortening of lower stereociliary rows.

Loxhd1 complete-deletion mouse Mouse measures Direct inner-hair-cell recordings measure reduced currents at P7 and P11 after complete deletion.

Downstream

Sensorineural Hearing Loss

Progressive Hair-Cell Degeneration

Progressive Stereociliary Degeneration

Show evidence (5 references)

PMID:33707295 SUPPORT INDIRECT Model Organism

"While mechanotransduction currents in mutant inner hair cells (IHCs) were similar to wild-type levels in the first postnatal week, they were severely affected by postnatal day 11."

Direct mouse recordings in the two PLAT10 alleles; indirect evidence for human hair-cell dysfunction, not a universal human progression schedule.

PMID:33707295 SUPPORT INDIRECT Model Organism

"The mechanotransduction defect observed in Loxhd1-mutant IHCs was not accompanied by a morphologic defect of the hair bundle or a reduction in TL number."

Gross bundle morphology and tip-link counts were preserved at the measured early stages; this does not exclude molecular channel mislocalization.

PMID:33707295 SUPPORT INDIRECT Model Organism

"we found that two proteins of the upper and lower TL protein complexes (Harmonin and LHFPL5) were maintained in the mutants, suggesting that the mechanotransduction machinery was present but not activatable"

The 2021 interpretation was based on two assayed tip-link proteins. Later direct TMC1 localization identifies a component that those measurements did not resolve.

+ 2 more references

BAIAP2L2 Mislocalization

In Loxhd1-null mouse inner hair cells, BAIAP2L2 remains detectable but redistributes from transducing stereociliary tips along the shafts, paralleling TMC1. This is a downstream localization readout; the experiments do not establish that BAIAP2L2 redistribution independently causes the hearing loss.

cochlear inner hair cell CL:0000589

stereocilium GO:0032420

Show evidence (1 reference)

PMID:39256406 SUPPORT Model Organism

"BAIAP2L2 is maintained at high levels in stereocilia but relocated away from the stereocilia tips, paralleling TMC1’s mislocalization."

P21 mouse immunofluorescence and immunogold localization distinguish redistribution from simple protein absence.

Progressive Hair-Cell Degeneration

Samba mouse hair cells eventually degenerate after functional impairment. This provides model-organism evidence for one possible substrate of human progression; congenital and relatively stable human hearing loss also occur.

auditory hair cell CL:0000202

Animal models

samba mouse (ENU-induced Loxhd1 mutant) Mouse recapitulates Hair-cell functional impairment precedes degeneration in the mouse. This is informative for the progressive subset of human disease but does not reproduce every congenital or stable clinical presentation.

Downstream

Sensorineural Hearing Loss

Show evidence (1 reference)

PMID:19732867 SUPPORT INDIRECT Model Organism

"Stereociliary development is unaffected in samba mice, but hair cell function is perturbed and hair cells eventually degenerate."

Mouse histology supports degeneration after dysfunction; it does not establish that degeneration precedes all human hearing loss.

Progressive Stereociliary Degeneration

In the complete Loxhd1 deletion mouse, the shortest inner-hair-cell stereociliary row progressively thins and disappears by P21; the second row develops marked tip-shape and width abnormalities by P60. These bundle changes follow early functional impairment and are distinct from loss of whole hair cells.

cochlear inner hair cell CL:0000589

stereocilium bundle GO:0032421

Downstream

Sensorineural Hearing Loss

Show evidence (1 reference)

PMID:39256406 SUPPORT Model Organism

"hair bundles of Loxhd1Delta/Delta apical IHCs showed a late thinning and progressive disappearance of row 3 stereocilia at P21 while row 2 tip shape and width were severely affected only at P60"

The structural sequence is age- and row-specific in the complete deletion mouse.

Relative Vestibular Sparing

Vestibular function has generally been preserved in assessed DFNB77 families, despite LOXHD1 expression in vestibular hair cells. The Dutch series found normal or mildly increased vestibular reactivity and some cVEMP asymmetry; the Japanese series reported no vertigo and normal formal vestibular testing in six individuals. These findings support relative clinical sparing, without proving a dose-dependent protective mechanism or excluding every vestibular abnormality.

vestibular hair cell CL:0000609

Show evidence (2 references)

PMID:29676012 SUPPORT Human Clinical

"There was no evidence for involvement of the vestibular system."

The Dutch authors found no disease-related vestibular deficit despite minor variations on some tests.

PMID:31547530 SUPPORT Human Clinical

"No accompanying symptoms, including vestibular dysfunction, with hearing loss were detected in this study."

The result concerns the LOXHD1-positive subgroup; six individuals had formal vestibular testing, not all 8,074 screened hearing-loss patients.

Sensorineural Hearing Loss

Impaired cochlear hair-cell function produces sensorineural hearing loss. The clinical range includes congenital and later-onset loss, stable and progressive courses, and mild through profound severity. The electrophysiological auditory-neuropathy presentation reported in some children does not by itself establish primary auditory-nerve degeneration.

Animal models

LOXHD1-associated hearing loss in Rottweilers Dog measures A naturally occurring recessive missense variant segregated with congenital or early-onset bilateral deafness in Rottweilers. Four affected littermates lacked auditory brainstem responses when tested.

Downstream

Sensorineural Hearing Impairment

Progressive Sensorineural Hearing Impairment

Prelingual Onset Hearing Loss

Congenital Sensorineural Hearing Impairment

High-Frequency Hearing Impairment

Tinnitus

Auditory Neuropathy Spectrum Disorder Presentation

Delayed Speech and Language Development

Show evidence (2 references)

PMID:29676012 SUPPORT Human Clinical

"The hearing phenotype showed high inter- and intrafamilial variation in severity and progression."

Human DFNB77 families show variable expressivity.

PMID:31547530 SUPPORT Human Clinical

"This study has revealed that most cases showed progressive HL or congenital deaf and some showed relatively stable HL."

The Japanese series includes contrasting courses and contains some uncertain genotypes.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

8

Ear 6

Sensorineural Hearing Impairment OBLIGATE HP:0000407

Show evidence (2 references)

PMID:29676012 SUPPORT Human Clinical

"In all subjects, HI was sensorineural and symmetric."

Clinical findings in the Dutch families.

PMID:31547530 SUPPORT Human Clinical

"Their severity of HL at the point of genetic examination varied from mild to profound"

The Japanese series documents a broad severity range.

Progressive Sensorineural Hearing Impairment HP:0000408

Course: PROGRESSIVE

Show evidence (3 references)

PMID:19732867 SUPPORT Human Clinical

"we screened DNA from human families segregating deafness and identified a mutation in LOXHD1, which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL)"

Names the phenotype and its progressive character in the founding human family.

PMID:31547530 SUPPORT Human Clinical

"To further assess the progression of HL, we evaluated the deterioration of hearing by obtaining serial audiograms from 14 individuals"

Longitudinal audiometry exists; the source reports variable individual deterioration.

PMID:21465660 REFUTE Human Clinical

"nine patients of Ashkenazi Jewish origin who had severe-profound congenital non-progressive ARNSHL and benefited from cochlear implants."

Counterevidence to progression as an obligatory feature.

Prelingual Onset Hearing Loss Prelingual sensorineural hearing impairment HP:0000399

Show evidence (3 references)

PMID:36472766 SUPPORT Human Clinical

"We identified eight pathogenic or likely pathogenic mutations in LOXHD1, GJB2, SLC26A4, MYO15A, and TMC1 from six families."

Places LOXHD1 among the genes solving prelingual-onset DFNB in this cohort, which is the basis for recording an early-onset presentation.

PMID:31547530 SUPPORT Human Clinical

"Patients with LOXHD1 variations mostly showed early onset hearing loss and presented different progression rates."

The Japanese cohort supports predominantly early onset, but early onset is not synonymous with prelingual onset.

PMID:34753855 REFUTE Human Clinical

"Four autosomal-recessive genes demonstrated an association with late hearing loss onset in single cases (TMPRSS3, GJB2, LOXHD1, and SLC26A4)."

Refutes prelingual onset as an obligate feature: in an age-balanced cohort LOXHD1 also turned up among the late-onset diagnoses. Recorded against this phenotype rather than omitted, so a reader does not take early onset as a rule-out for late presentation.

Congenital Sensorineural Hearing Impairment HP:0008527

Show evidence (1 reference)

PMID:21465660 SUPPORT Human Clinical

"nine patients of Ashkenazi Jewish origin who had severe-profound congenital non-progressive ARNSHL and benefited from cochlear implants."

Direct clinical evidence for a congenital non-progressive presentation.

High-Frequency Hearing Impairment HP:0005101

Show evidence (1 reference)

PMID:26973026 SUPPORT Human Clinical

"The two sisters, who had either mild or severe high-frequency hearing loss"

The Japanese family directly supports high-frequency involvement.

Tinnitus HP:0000360

Show evidence (1 reference)

PMID:31547530 SUPPORT Human Clinical

"A total of 6 out of 21 patients (28.5%) complained of tinnitus, and none of vertigo."

The denominator is respondents with this assessment, not all screened hearing-loss patients.

Nervous System 2

Auditory Neuropathy Spectrum Disorder Presentation Abnormal auditory evoked potentials HP:0006958

Show evidence (2 references)

PMID:35875410 SUPPORT Human Clinical

"All three subjects had evidence of some, albeit few, functioning cochlear hair cells as revealed by the presence of a cochlear microphonic and/or partial otoacoustic emissions early in life."

Three relatives retained some early cochlear responses; the paper specifically identifies the two sisters as presynaptic ANSD cases.

PMID:35875410 SUPPORT Human Clinical

"To our knowledge, this is the first association between LOXHD1 mutations and ANSD in two patients who have been successfully managed with cochlear implants."

Establishes the association as novel at the time of reporting and records the management outcome, which is why this presentation matters clinically rather than only descriptively.

Delayed Speech and Language Development HP:0000750

Show evidence (1 reference)

PMID:35875410 SUPPORT Human Clinical

"The assessment revealed significant delayed receptive and expressive language skills."

A language assessment in the younger sister before implantation documented delay; later language development improved.

🧬

Genetic Associations

1

LOXHD1

Gene: LOXHD1 hgnc:26521 relationship_type: CAUSATIVE

Show evidence (3 references)

PMID:19732867 SUPPORT Human Clinical

"Based on the studies in mice, we screened DNA from human families segregating deafness and identified a mutation in LOXHD1, which causes DFNB77"

The gene-disease relationship and, in the same sentence, the mouse-first route by which it was established.

PMID:34753855 SUPPORT Human Clinical

"At the single-gene level, causative variants in GJB2 were the most common cause among autosomal-recessive genes (45%), followed by MYO15A and SLC26A4 (both 10%), TMPRSS3 and LOXHD1 (both 7%)."

Quantifies LOXHD1's share among autosomal recessive diagnoses in an unselected cohort, which is what establishes it as a routine contributor rather than a single-family gene.

PMID:37441688 SUPPORT Other

"Our review of reported variants in LOXHD1 with respect to segregation in FECD families and data on LOXHD1 expression in corneal endothelium did not reveal any pathogenic variants."

The systematic reassessment challenges the proposed Fuchs dystrophy association. This supports keeping that association uncertain rather than treating corneal dystrophy as a DFNB77 manifestation.

Variants (6)

c.4212+1G>A

Recurrent splice-donor variant found in nine homozygous and nine compound heterozygous individuals in the 2019 Japanese LOXHD1-variant cohort. Differing haplotypes in six homozygotes favored recurrent origins. The paper also notes this allele in population databases outside Japan.

Show evidence (1 reference)

PMID:31547530 SUPPORT Human Clinical

"A recurrent variant c.4212 + 1G > A, only reported in Japanese patients, was detected in 18 individuals. Haplotype analysis implied that this variation occurred in a mutational hot spot, and that multiple ancestors of Japanese population had this variation."

The abstract describes the published patient reports then available; population restriction is not established. Haplotype results oppose a simple single-founder assumption.

p.D278Y and p.D1219E compound heterozygous pair

Novel compound heterozygous LOXHD1 alleles reported in a Pakistani family with prelingual autosomal recessive nonsyndromic hearing loss. Both are missense changes at conserved residues.

Show evidence (1 reference)

PMID:36472766 SUPPORT Human Clinical

"The compound heterozygous mutations in LOXHD1 ([p.D278Y] + [p.D1219E])"

The abstract explicitly identifies the two LOXHD1 alleles; this does not represent six LOXHD1 families.

p.Arg1572Ter

Homozygous nonsense variant in nine Ashkenazi Jewish patients with congenital non-progressive severe-to-profound hearing loss.

Show evidence (1 reference)

PMID:21465660 SUPPORT Human Clinical

"a novel homozygous mutation of the LOXHD1 gene resulting in a premature stop codon (R1572X) in nine patients of Ashkenazi Jewish origin"

Direct genotype and clinical association.

c.5934C>T synonymous splice-altering variant

A synonymous variant in a Dutch family activated a novel splice donor in a HEK293T minigene assay. The assay supports abnormal splicing rather than an amino-acid substitution mechanism.

Show evidence (1 reference)

PMID:29676012 SUPPORT In Vitro

"the c.5934C>T variant indeed abolished nor- mal splicing"

The source reports altered minigene splicing through a novel donor; the line-break hyphen is preserved from the cached PDF.

p.Arg1494Ter and p.Glu1957Ter compound heterozygous pair

Two Japanese siblings with moderate or severe loss had compound heterozygous truncating variants and stable hearing during the reported childhood follow-up.

Show evidence (1 reference)

PMID:25792669 SUPPORT Human Clinical

"We identified compound heterozygous mutations; c.5869G>T, p.E1957X and c.4480C>T, p.R1494X in LOXHD1 gene in two patients of family number 963."

Directly identifies the alleles and family.

p.Val1892Phe

Reported in trans with c.4212+1G>A in two Japanese sisters. Predicted PLAT-domain distortion and reduced membrane affinity are computational hypotheses, not measured binding defects.

Show evidence (1 reference)

PMID:26973026 SUPPORT Computational

"Molecular modeling predicted that distorted structure of the PLAT domain in the p.V1892F mutant could lead to decreased affinity of the protein to lipid membrane resulting in hair cell dysfunction."

SWISS-MODEL prediction; a direct lipid-binding defect was not measured.

💊

Medical Actions

4

Hearing Aid Amplification

Action: hearing aid amplification Ontology label: Rehabilitation NCIT:C15315

Platform: Device

Hearing aids provide amplification when residual hearing permits useful benefit. Fitting and follow-up should assess aided hearing and language development. In a reported LOXHD1 family, the cousin had aided thresholds in the mild range but persistent language delay, while two sisters had limited benefit and proceeded to cochlear implantation.

Mechanism Target:

Sensorineural Hearing Loss — Improves access to sound without correcting the underlying mechanotransduction defect.

Show evidence (3 references)

PMID:35875410 SUPPORT Human Clinical

"The cousin proband was fitted with hearing aids at 6 months of age."

The cousin received amplification; aided thresholds and speech reception improved, but language remained delayed.

PMID:35875410 SUPPORT Human Clinical

"Although still delayed, he is currently making progress in terms of speech and language development and remains closely followed with a cochlear implant candidacy evaluation pending on the rate of language development and potential worsening of his hearing loss."

An aided audiogram alone did not establish adequate language access; ongoing assessment was required.

url:https://www.ncbi.nlm.nih.gov/books/NBK1434/ SUPPORT Other

"Hearing aids (sound amplification), ... customized by an audiologist to the degree and frequency of hearing loss, can be used in individuals with mild-to-severe hearing loss."

General genetic hearing-loss guidance supports individualized amplification, not a DFNB77-specific response rate.

Cochlear Implantation

Action: cochlear device implantation Ontology label: Surgical Procedure NCIT:C15329

Platform: Device

Cochlear implantation can provide useful auditory and language outcomes in selected individuals with severe-to-profound LOXHD1-associated hearing loss. Benefit is reported in an Ashkenazi Jewish series, four assessed Japanese recipients, and two sisters with an auditory-neuropathy presentation. These small observational reports do not establish a universal response rate or a genotype-specific optimal implantation age.

Mechanism Target:

Reduced Hair-Cell Mechanotransduction — Electrical stimulation bypasses impaired hair-cell mechanotransduction. Secondary spiral-ganglion degeneration in mouse models does not establish a human timing threshold for implantation.

Show evidence (4 references)

PMID:35875410 SUPPORT Human Clinical

"To our knowledge, this is the first association between LOXHD1 mutations and ANSD in two patients who have been successfully managed with cochlear implants."

The reported outcome. Two patients is a small basis, and the entry does not present this as an established outcome rate for DFNB77 - only that implantation succeeded where it was tried and reported.

PMID:21465660 SUPPORT Human Clinical

"nine patients of Ashkenazi Jewish origin who had severe-profound congenital non-progressive ARNSHL and benefited from cochlear implants."

The original clinical report supplies independent evidence of benefit.

PMID:31547530 SUPPORT Human Clinical

"all four cases for which we were able to obtain the results of the Japanese monosyllable word and sentence perception tests, showed over 90% correctness."

Four of eight implant recipients had assessed outcomes; the paper reports these results six months after surgery. The full variant cohort includes uncertain genotypes.

+ 1 more reference

Genetic Counseling

Action: Genetic Counseling NCIT:C15240

Platform: Behavioral / lifestyle

Counseling addresses autosomal recessive inheritance, variant classification and phase, reproductive options, and the variable hearing-loss course. When both parents carry the relevant pathogenic LOXHD1 alleles, each pregnancy has a 25% chance of an affected child. Congenital stable and progressive courses are both documented; genotype alone does not reliably predict an individual trajectory.

Show evidence (2 references)

url:https://www.ncbi.nlm.nih.gov/books/NBK1434/ SUPPORT Other

"If both parents are known to be ... heterozygous ... autosomal recessive ... hearing loss-related ... pathogenic variant ... has at conception a 25% chance of having hearing loss"

General Mendelian counseling applies to confirmed biallelic DFNB77 when the parental carrier genotypes are established.

PMID:21465660 SUPPORT Human Clinical

"nine patients of Ashkenazi Jewish origin who had severe-profound congenital non-progressive ARNSHL and benefited from cochlear implants."

Counseling must include the possibility of non-progressive hearing loss.

Speech, Language and Communication Support

Action: speech and language therapy Ontology label: Speech Language Therapy NCIT:C159273

Platform: Behavioral / lifestyle

Early, individualized language and communication support accompanies audiologic care. Speech-language services, educational accommodations and D/deaf and hard-of-hearing resources should be adapted to the child and family. Hearing thresholds alone do not establish language development.

Mechanism Target:

Delayed Speech and Language Development — Supports language access and development alongside auditory rehabilitation.

Show evidence (1 reference)

url:https://www.ncbi.nlm.nih.gov/books/NBK1434/ SUPPORT Other

"A speech-language therapist as well as a neuropsychologist/psychologist for children with hearing loss provides access to resources within the community to aid in speech and language and D/deaf and hard of hearing (DHH) identity development."

General hearing-loss guidance supports language and communication services; no controlled DFNB77-specific intervention trial is implied.

🔬

Diagnosis

2

Hearing Loss Gene Panel or Exome Sequencing

Molecular diagnosis uses a hearing-loss multigene panel or genomic testing, with assessment of variant pathogenicity, biallelic phase and segregation. The phenotype overlaps other genetic hearing losses. Panel yield depends on cohort selection and test coverage; the German study does not establish that a panel is always sufficient for DFNB77.

Show evidence (4 references)

PMID:34753855 SUPPORT Human Clinical

"A positive family history of autosomal-recessive inheritance in combination with early onset and higher grades of hearing loss significantly increased the solve rate up to 60%, while late onset and lower grades of hearing loss yielded significantly fewer diagnoses."

The reported solve rate applies to a selected subgroup across hearing-loss genes, not a DFNB77-specific diagnostic sensitivity.

PMID:34753855 SUPPORT Human Clinical

"Targeted hearing loss gene panel analysis proved to be an effective tool for ensuring an appropriate diagnostic yield in a routine clinical setting including the identification of novel variants and medically significant reclassifications."

Supports panel sequencing as the routine diagnostic modality for this class of disease.

url:https://www.ncbi.nlm.nih.gov/books/NBK1434/ SUPPORT Other

"The identification of variant(s) of ... uncertain significance ... cannot be used to confirm or rule out the diagnosis."

A pair of uncertain LOXHD1 variants is not equivalent to a confirmed molecular diagnosis.

+ 1 more reference

Audiological Testing Including Otoacoustic Emissions and Cochlear Microphonic

Audiometry, otoacoustic emissions, auditory brainstem responses and cochlear microphonic assessment characterize the hearing phenotype. Testing for preserved cochlear responses alongside disordered brainstem responses can identify an auditory-neuropathy pattern. Serial audiometry assesses progression without assuming that every patient will deteriorate.

Show evidence (1 reference)

PMID:35875410 SUPPORT Human Clinical

"They were assessed with a standard clinical test battery including distortion otoacoustic emissions, auditory brainstem responses and audiometry."

The test battery used, and the one that made the ANSD presentation visible.

📈

Progression

2

Onset

Age: prelingual to late onset

Onset ranges from congenital to later life in published cohorts. Delayed diagnosis does not necessarily establish delayed biological onset; a passed newborn screen followed by loss is more informative than absence of neonatal testing.

Show evidence (1 reference)

PMID:34753855 SUPPORT Human Clinical

"Four autosomal-recessive genes demonstrated an association with late hearing loss onset in single cases (TMPRSS3, GJB2, LOXHD1, and SLC26A4)."

The late-onset end of the reported range.

Established disease

Both stable and progressive courses occur. The Japanese cohort obtained serial audiograms in 14 individuals and reported deterioration rates of 0.1 to 9.3 dB/year in pure-tone average. These rates describe that observed subset rather than a universal trajectory. The Dutch series also analyzed longitudinal audiograms and found both stable and progressive hearing loss.

Show evidence (2 references)

PMID:31547530 SUPPORT Human Clinical

"The deterioration rate varied from 0.1 dB/year to 9.3 dB/year in PTA (mean rate: 3.5 dB/year)."

Serial audiograms were available for 14 individuals; cohort selection and variant uncertainty limit generalization.

PMID:25792669 SUPPORT Human Clinical

"His hearing was unchanged from 6 to 9 years old."

A child with compound heterozygous truncating variants had stable measured hearing over this interval.

📊

Prevalence

2

Japanese hearing-loss patients screened by massively parallel sequencing

Unknown Unknown

The 2019 study identified 28 affected individuals from 25 families carrying LOXHD1 variants among 8,074 Japanese hearing-loss patients. This is an ascertained cohort, not a population prevalence estimate. Some variants were uncertain, segregation was incomplete in some families, and the authors questioned two relatively frequent missense alleles; 28 is therefore not an unqualified count of definitively solved probands.

Show evidence (1 reference)

PMID:31547530 SUPPORT Human Clinical

"In this study, genetic screening was conducted on 8074 Japanese hearing loss patients utilizing massively parallel DNA sequencing to identify individuals with LOXHD1 variants and to assess their phenotypes. A total of 28 affected individuals and 21 LOXHD1 variants were identified, among which 13..."

Screening denominator and reported LOXHD1-positive group; read alongside the study limitations on pathogenicity and phase.

Hearing-impaired probands, age-balanced German diagnostic cohort

Unknown Unknown

LOXHD1 accounted for three of 75 molecular diagnoses in a German diagnostic series of 305 hearing-impaired probands. The reported 7% refers to its share among autosomal recessive diagnoses, not population prevalence.

Show evidence (3 references)

PMID:34753855 SUPPORT Human Clinical

"A genetic diagnosis was established for 75 (25%) of the probands that involved 75 causal variants in 35 genes, including 16 novel causal variants and 9 medically significant variant reclassifications."

The denominator for the yield figure - 25% of 305 probands solved.

PMID:34753855 SUPPORT Human Clinical

"Nearly one-quarter of the cases (23%; n = 17) were associated with variants in seven additional genes (TMPRSS3, COL4A3, LOXHD1, EDNRB, MYO6, TECTA, and USH2A)."

Places LOXHD1 in the second tier of contributing genes in that cohort.

PMID:34753855 SUPPORT Human Clinical

"TMPRSS3, COL4A3, and LOXHD1 (each 4%; n = 3)"

The gene-specific count is three of 75 solved cases.

🐁

Animal Models

4

samba mouse (ENU-induced Loxhd1 mutant)

ENU-induced mouse allele that helped identify LOXHD1-related human hearing loss. It models loss of hair-cell function followed by degeneration, with allele-specific timing.

Species

Mouse

Genotype

Homozygous Loxhd1 samba p.Ile1342Asn (PLAT10)

Publication

PMID:19732867

Pathograph links

Progressive Hair-Cell Degeneration recapitulates fidelity: moderate Hair-cell functional impairment precedes degeneration in the mouse. This is informative for the progressive subset of human disease but does not reproduce every congenital or stable clinical presentation.

Limitations: A mouse point allele standing in for a range of human variants. The correspondence of a particular human genotype's severity to the samba phenotype has not been established, and the human onset range is wide.

Readouts

Hair-cell survival over age

Direction: DECREASED

Interpretation: The mouse temporal sequence supports functional impairment preceding cell loss; the human course is variable.

Show evidence (1 reference)

PMID:19732867 SUPPORT Model Organism

"Stereociliary development is unaffected in samba mice, but hair cell function is perturbed and hair cells eventually degenerate."

Reports the histological and functional sequence behind this readout.

Show evidence (1 reference)

PMID:19732867 SUPPORT Model Organism

"We show that hearing loss in the ethylnitrosourea (ENU)-induced samba mouse line is caused by a mutation in Loxhd1."

The original abstract identifies the causal Loxhd1 mutation in samba mice.

Loxhd1 PLAT10 samba and T1308X mouse comparison

Comparison of an ENU-derived missense allele with an engineered premature-stop/deletion allele. T1308X is not a complete null: nonsense-associated alternative splicing can preserve an open reading frame, and residual hearing is milder in some animals.

Species

Mouse

Genotype

Homozygous samba p.Ile1342Asn or engineered p.T1308X_P1420del

Publication

PMID:33707295

Pathograph links

Reduced Hair-Cell Mechanotransduction measures fidelity: moderate Direct measurements show near-normal first-week inner-hair-cell mechanotransduction currents followed by severe impairment at P11. Gross bundle organization and tip links are preserved at these ages, despite modest shortening of lower stereociliary rows.

Limitations: Mouse timing and allele effects cannot be assumed for all human variants. Residual hearing in T1308X animals may reflect alternative splicing; nearby genetic modifiers were not excluded. Maintained Harmonin and LHFPL5 do not establish that all channel components remain normally localized.

Readouts

Mechanotransduction current in inner hair cells at postnatal day 11

Direction: DECREASED

Interpretation: The failing step, with a normal first postnatal week as the internal control that dates the onset.

Show evidence (1 reference)

PMID:33707295 SUPPORT Model Organism

"While mechanotransduction currents in mutant inner hair cells (IHCs) were similar to wild-type levels in the first postnatal week, they were severely affected by postnatal day 11."

Reports the electrophysiological measurement behind this readout.

Tip-link number and hair-bundle morphology

Direction: UNCHANGED

Interpretation: Preserved gross organization and tip-link number argue against their loss as the proximate explanation, while allowing subtle structural changes and molecular mislocalization.

Show evidence (1 reference)

PMID:33707295 SUPPORT Model Organism

"The mechanotransduction defect observed in Loxhd1-mutant IHCs was not accompanied by a morphologic defect of the hair bundle or a reduction in TL number."

Reports the structural measurements behind this readout.

Harmonin and LHFPL5 localisation in the hair bundle

Direction: UNCHANGED

Interpretation: The localization of these two proteins is maintained. Other components were not adequately assessed in this experiment; the later complete-deletion model demonstrates TMC1 mislocalization.

Show evidence (1 reference)

PMID:33707295 SUPPORT Model Organism

"we found that two proteins of the upper and lower TL protein complexes (Harmonin and LHFPL5) were maintained in the mutants"

Reports the immunolocalisation measurement behind this readout.

Show evidence (2 references)

PMID:33707295 SUPPORT Model Organism

"Here, we identified the hearing loss-associated Loxhd1/DFNB77 gene as being required for the mechanotransduction process."

Supports treating this model as informative for the transduction node, and names the human locus explicitly.

+ 1 more reference

Loxhd1 complete-deletion mouse

Large-scale deletion establishes that LOXHD1 maintains TMC1 at the lower tip-link insertion. Remaining TMC1 redistributes along stereociliary shafts, while TMC2 localization is preserved. Inner-hair-cell currents are already reduced at P7 and become more severely impaired at P11.

Species

Mouse

Genotype

Homozygous Loxhd1Delta deletion removing all 15 PLAT domains

Publication

PMID:39256406

Pathograph links

TMC1 Mislocalization from Tip-Link Insertion Sites measures fidelity: moderate Large-scale deletion establishes that LOXHD1 maintains TMC1 at the lower tip-link insertion. Remaining TMC1 redistributes along stereociliary shafts, while TMC2 localization is preserved. Inner-hair-cell currents are already reduced at P7 and become more severely impaired at P11.

Limitations: This engineered large deletion does not represent the full spectrum of human alleles. Some residual currents remain; mild heterozygote mouse threshold changes do not establish dominant human DFNB77.

Show evidence (1 reference)

PMID:39256406 SUPPORT Model Organism

"In P21 Loxhd1Delta/Delta IHCs, TMC1 molecules were not confined to stereocilia tips and could instead be found mislocalized along stereocilia shafts."

Super-resolution localization directly demonstrates displacement of remaining TMC1.

Reduced Hair-Cell Mechanotransduction measures fidelity: moderate Direct inner-hair-cell recordings measure reduced currents at P7 and P11 after complete deletion.

Limitations: Developmental mouse timing and a complete deletion cannot predict the course of every human allele.

Readouts

Inner-hair-cell mechanotransduction current

Direction: DECREASED

Interpretation: Complete deletion impairs currents earlier than PLAT10-limited mutations, with residual activity still present.

Show evidence (1 reference)

PMID:39256406 SUPPORT Model Organism

"the complete absence of LOXHD1 leads to earlier effects on IHC MET currents at P7 (33% amplitude reduction), which continues to an 84% reduction at P11."

The comparison defines the allele-specific temporal difference.

Show evidence (1 reference)

PMID:39256406 SUPPORT Model Organism

"the complete absence of LOXHD1 leads to earlier effects on IHC MET currents at P7 (33% amplitude reduction), which continues to an 84% reduction at P11."

The comparison defines the allele-specific temporal difference.

LOXHD1-associated hearing loss in Rottweilers

A naturally occurring recessive missense variant segregated with congenital or early-onset bilateral deafness in Rottweilers. Four affected littermates lacked auditory brainstem responses when tested.

Species

Dog

Genotype

Homozygous LOXHD1 p.Gly1914Ala

Publication

PMID:33983508

Pathograph links

Sensorineural Hearing Loss measures fidelity: moderate A naturally occurring recessive missense variant segregated with congenital or early-onset bilateral deafness in Rottweilers. Four affected littermates lacked auditory brainstem responses when tested.

Limitations: Variant segregation and hearing tests support a large-animal model, but this study did not measure mechanotransduction or hair-cell histology in the genotyped dogs. Histological degeneration described in earlier ungenotyped Rottweilers cannot be attributed definitively to this allele. Progression from partial loss to deafness was inferred from owner reports and remains unconfirmed.

Show evidence (2 references)

PMID:33983508 SUPPORT Model Organism

"We observed complete segregation of the variant with hearing loss, as all four affected dogs were homozygous for the variant."

The 585-dog cohort included four affected homozygotes; unaffected dogs were heterozygous or wild type.

+ 1 more reference

{ }

Source YAML

click to show

name: Autosomal Recessive Nonsyndromic Hearing Loss 77
category: Mendelian
creation_date: '2026-08-30T22:05:00Z'
synonyms:
- DFNB77
- Deafness, autosomal recessive 77
- LOXHD1-related autosomal recessive nonsyndromic hearing loss
- Autosomal recessive nonsyndromic deafness 77
description: 'DFNB77 is autosomal recessive nonsyndromic sensorineural hearing loss caused by biallelic pathogenic variants in LOXHD1. Onset, severity and course vary: congenital and later-onset presentations, mild to profound impairment, and stable as well as progressive courses have been reported. Some children have an auditory neuropathy spectrum presentation. LOXHD1 is a multi-PLAT-domain stereociliary protein required to maintain mature TMC1-containing mechanotransduction channels near the lower tip-link insertion. Mouse loss of LOXHD1 progressively reduces and mislocalizes stereociliary TMC1, impairing mechanical activation while developmental TMC2 localization is preserved. Functional failure can precede substantial bundle degeneration. These mouse findings explain a molecular route to hearing loss but do not dictate the onset or course of every human genotype.'
disease_term:
preferred_term: autosomal recessive nonsyndromic hearing loss 77
term:
id: MONDO:0013119
label: autosomal recessive nonsyndromic hearing loss 77
parents:
- Nonsyndromic Hearing Loss
notes: DFNB77 is OMIM 613079; LOXHD1 is OMIM 613072. Human series show substantial variation even within families, and variant type or position alone has not reliably predicted an individual's course. Negative genotype-phenotype analyses in small cohorts do not establish that no correlation can exist. Vestibular function was generally preserved in the assessed cohorts; minor test variations and limited sampling prevent a universal absence claim. The proposed association of heterozygous LOXHD1 variants with Fuchs endothelial corneal dystrophy remains uncertain and should not be treated as an established DFNB77 manifestation. Cohort detection proportions are distinct from population prevalence, and reported LOXHD1-positive cohorts sometimes include variants of uncertain significance or incompletely established phase.
inheritance:
- name: Autosomal recessive
description: Biallelic LOXHD1 variants. Reported as homozygous in consanguineous families and as compound heterozygous elsewhere.
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
evidence:
- reference: PMID:19732867
reference_title: Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: we screened DNA from human families segregating deafness and identified a mutation in LOXHD1, which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL)
explanation: Establishes the recessive inheritance and names the locus.
- reference: PMID:29676012
reference_title: Further audiovestibular characterization of DFNB77, caused by deleterious variants in LOXHD1, and investigation into the involvement of Fuchs corneal dystrophy.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: 'All variants were detected in a compound heterozygous state and all

segregated with HI in the families.'
explanation: The Dutch cohort directly supports compound heterozygous inheritance.
- reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1434/
reference_title: Genetic Hearing Loss Overview - GeneReviews® - NCBI Bookshelf
supports: SUPPORT
evidence_source: OTHER
snippet: If both parents are known to be ... heterozygous ... autosomal recessive ... hearing loss-related ... pathogenic variant ... has at conception a 25% chance of having hearing loss
explanation: General Mendelian counseling applies to confirmed biallelic DFNB77 when the parental carrier genotypes are established.
pathophysiology:
- name: LOXHD1 Loss of Function in Stereocilia
description: 'Biallelic pathogenic LOXHD1 variants impair a stereociliary protein containing up to fifteen PLAT repeats. The molecular consequence is allele dependent: missense variants need not remove the protein, and nonsense-associated alternative splicing can preserve part of its coding sequence in a mouse model. Epitope-tagged mouse LOXHD1 is enriched at the tips of the shorter, transducing stereocilia. Earlier staining along the stereociliary membrane used an antibody whose specificity could not be confirmed with a complete null control.'
biological_scale: MOLECULAR
genes:
- preferred_term: LOXHD1
term:
id: hgnc:26521
label: LOXHD1
genetic_context:
functional_impact_category: LOSS_OF_FUNCTION
allele_type: VARIANT
variant_origin: GERMLINE
cellular_components:
- preferred_term: stereocilium
term:
id: GO:0032420
label: stereocilium
cell_types:
- &id001
preferred_term: cochlear inner hair cell
term:
id: CL:0000589
label: cochlear inner hair cell
- &id002
preferred_term: cochlear outer hair cell
term:
id: CL:0000601
label: cochlear outer hair cell
downstream:
- target: Reduced Stereociliary TMC1 Abundance
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- target: TMC1 Mislocalization from Tip-Link Insertion Sites
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:19732867
reference_title: Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: LOXHD1 consists entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains and is expressed along the membrane of mature hair cell stereocilia.
explanation: The protein's composition and its subcellular location, which together define this node.
- reference: PMID:33707295
reference_title: Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells.
supports: SUPPORT
directness: INDIRECT
evidence_source: MODEL_ORGANISM
snippet: LOXHD1 consists of 15 polycystin lipoxygenase α-toxin (PLAT) repeats, which in other proteins can bind lipids and proteins.
explanation: The repeat count and the functional class of the repeats. INDIRECT because the inference that LOXHD1's repeats bind lipids and proteins is carried over from other PLAT-domain proteins rather than demonstrated for LOXHD1 - the authors' own hedge "in other proteins" is kept in the quote.
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: We infer from these results that LOXHD1 proteins localized preferentially at the tips of rows 2 and 3, in the same subcellular domain as the MET channel complexes and where the lower part of the tip link inserts into the stereocilia membrane.
explanation: HA-tagged knock-in localization refines the earlier membrane-wide antibody pattern.
- reference: PMID:33707295
reference_title: Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: The premature termination codon of the Loxhd1T1308X allele did not trigger nonsense-mediated mRNA decay
explanation: The engineered PLAT10 allele is not a complete null; the source demonstrated alternative splicing that preserves an open reading frame.
- name: Reduced Stereociliary TMC1 Abundance
description: Loss of LOXHD1 reduces the number of stereocilia retaining TMC1, with marked depletion from the shortest row. Initial TMC1 entry into stereocilia still occurs, distinguishing defective maintenance from complete failure of initial delivery. TMC2 tip localization is preserved, LHFPL5 remains localized, and TMIE is partly reduced. CIB2 immunostaining appeared maintained, but antibody background limited precise assessment.
biological_scale: CELLULAR
cell_types:
- preferred_term: cochlear inner hair cell
term:
id: CL:0000589
label: cochlear inner hair cell
- preferred_term: cochlear outer hair cell
term:
id: CL:0000601
label: cochlear outer hair cell
cellular_components:
- preferred_term: stereocilium
term:
id: GO:0032420
label: stereocilium
downstream:
- target: Reduced Hair-Cell Mechanotransduction
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: First, the quantities of TMC1 molecules were progressively reduced in stereocilia, suggesting that LOXHD1 is not indispensable for the initial presence of TMC1 in the stereocilia
explanation: Localization measurements in the complete deletion model support a maintenance defect rather than an absolute entry requirement.
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: Therefore, the absence of LOXHD1 had no effect on TMC2 hair bundle row 2 tip localization or expression time.
explanation: The TMC2 result helps explain residual early mechanotransduction.
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: we could not determine with accuracy if CIB2 was affected by LOXHD1’s absence.
explanation: The authors explicitly qualify their CIB2 localization result.
- name: TMC1 Mislocalization from Tip-Link Insertion Sites
description: Remaining TMC1 molecules progressively redistribute away from the lower tip-link insertion along stereociliary shafts. This spatial separation limits transmission of sound-induced forces to the channels. LOXHD1 co-immunoprecipitates with TMC1, CIB2, LHFPL5 and PCDH15-CD2 in heterologous cells, but not with TMC2 or TMIE in the tested assays. These associations and mouse localization support a stabilizing connection; they do not establish the exact direct-binding topology or show that every human variant disrupts the same interaction.
biological_scale: CELLULAR
cell_types:
- preferred_term: cochlear inner hair cell
term:
id: CL:0000589
label: cochlear inner hair cell
- preferred_term: cochlear outer hair cell
term:
id: CL:0000601
label: cochlear outer hair cell
cellular_components:
- preferred_term: stereocilium
term:
id: GO:0032420
label: stereocilium
downstream:
- target: Reduced Hair-Cell Mechanotransduction
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- target: BAIAP2L2 Mislocalization
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: LOXHD1 is also critical for maintenance of TMC1 within the first 100 nm of the row 2 tips, where the tip links insert and where the mechanical stimuli are received.
explanation: SUB-immunogold-SEM mapped endogenous tagged TMC1 relative to the insertion site in mouse hair cells.
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: These experiments demonstrate that LOXHD1 interacts selectively in vitro with TMC1 but not with TMC2.
explanation: HEK293T co-immunoprecipitation distinguishes the paralogues under the tested conditions.
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: LOXHD1 interacts selectively with three of the five known MET channel complex proteins TMC1, CIB2, and LHFPL5 plus the lower-tip link protein PCDH15
explanation: Co-immunoprecipitation supports association with these components; direct molecular contacts remain incompletely resolved.
- name: Reduced Hair-Cell Mechanotransduction
description: Mechanically evoked receptor currents decline in LOXHD1-mutant cochlear hair cells before gross bundle disruption. PLAT10 missense and targeted truncating mouse alleles retain near-control currents at P7 but show severe reduction at P11, with unchanged measured residual-current kinetics at P9. A complete Loxhd1 deletion already reduces currents at P7 and leaves small residual currents at P11. Tip links and selected tip-link proteins can remain present despite TMC1 mislocalization; their presence does not demonstrate an intact channel complex. Human onset and progression cannot be inferred directly from these postnatal mouse time points.
biological_scale: CELLULAR
cell_types:
- *id001
- *id002
biological_processes:
- preferred_term: mechanotransduction in cochlear hair cells
modifier: DECREASED
term:
id: GO:0050910
label: detection of mechanical stimulus involved in sensory perception of sound
cellular_components:
- preferred_term: stereocilium bundle
term:
id: GO:0032421
label: stereocilium bundle
downstream:
- target: Sensorineural Hearing Loss
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- target: Progressive Hair-Cell Degeneration
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- target: Progressive Stereociliary Degeneration
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:33707295
reference_title: Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells.
supports: SUPPORT
directness: INDIRECT
evidence_source: MODEL_ORGANISM
snippet: While mechanotransduction currents in mutant inner hair cells (IHCs) were similar to wild-type levels in the first postnatal week, they were severely affected by postnatal day 11.
explanation: Direct mouse recordings in the two PLAT10 alleles; indirect evidence for human hair-cell dysfunction, not a universal human progression schedule.
- reference: PMID:33707295
reference_title: Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells.
supports: SUPPORT
directness: INDIRECT
evidence_source: MODEL_ORGANISM
snippet: The mechanotransduction defect observed in Loxhd1-mutant IHCs was not accompanied by a morphologic defect of the hair bundle or a reduction in TL number.
explanation: Gross bundle morphology and tip-link counts were preserved at the measured early stages; this does not exclude molecular channel mislocalization.
- reference: PMID:33707295
reference_title: Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells.
supports: SUPPORT
directness: INDIRECT
evidence_source: MODEL_ORGANISM
snippet: we found that two proteins of the upper and lower TL protein complexes (Harmonin and LHFPL5) were maintained in the mutants, suggesting that the mechanotransduction machinery was present but not activatable
explanation: The 2021 interpretation was based on two assayed tip-link proteins. Later direct TMC1 localization identifies a component that those measurements did not resolve.
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: the complete absence of LOXHD1 leads to earlier effects on IHC MET currents at P7 (33% amplitude reduction), which continues to an 84% reduction at P11.
explanation: The large deletion differs from the partial PLAT10 alleles and retains measurable residual currents.
- reference: PMID:33707295
reference_title: Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: mutations in the LOXHD1 PLAT10 repeat reduce the IHC current amplitude without modifying kinetic properties.
explanation: Residual-current kinetics were assessed at P9; this does not establish absence of every possible gating effect.
- name: BAIAP2L2 Mislocalization
description: In Loxhd1-null mouse inner hair cells, BAIAP2L2 remains detectable but redistributes from transducing stereociliary tips along the shafts, paralleling TMC1. This is a downstream localization readout; the experiments do not establish that BAIAP2L2 redistribution independently causes the hearing loss.
biological_scale: CELLULAR
cell_types:
- preferred_term: cochlear inner hair cell
term:
id: CL:0000589
label: cochlear inner hair cell
cellular_components:
- preferred_term: stereocilium
term:
id: GO:0032420
label: stereocilium
evidence:
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: BAIAP2L2 is maintained at high levels in stereocilia but relocated away from the stereocilia tips, paralleling TMC1’s mislocalization.
explanation: P21 mouse immunofluorescence and immunogold localization distinguish redistribution from simple protein absence.
- name: Progressive Hair-Cell Degeneration
description: Samba mouse hair cells eventually degenerate after functional impairment. This provides model-organism evidence for one possible substrate of human progression; congenital and relatively stable human hearing loss also occur.
biological_scale: CELLULAR
cell_types:
- preferred_term: auditory hair cell
term:
id: CL:0000202
label: auditory hair cell
downstream:
- target: Sensorineural Hearing Loss
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:19732867
reference_title: Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans.
supports: SUPPORT
directness: INDIRECT
evidence_source: MODEL_ORGANISM
snippet: Stereociliary development is unaffected in samba mice, but hair cell function is perturbed and hair cells eventually degenerate.
explanation: Mouse histology supports degeneration after dysfunction; it does not establish that degeneration precedes all human hearing loss.
- name: Progressive Stereociliary Degeneration
description: In the complete Loxhd1 deletion mouse, the shortest inner-hair-cell stereociliary row progressively thins and disappears by P21; the second row develops marked tip-shape and width abnormalities by P60. These bundle changes follow early functional impairment and are distinct from loss of whole hair cells.
biological_scale: CELLULAR
cell_types:
- preferred_term: cochlear inner hair cell
term:
id: CL:0000589
label: cochlear inner hair cell
cellular_components:
- preferred_term: stereocilium bundle
term:
id: GO:0032421
label: stereocilium bundle
downstream:
- target: Sensorineural Hearing Loss
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: hair bundles of Loxhd1Delta/Delta apical IHCs showed a late thinning and progressive disappearance of row 3 stereocilia at P21 while row 2 tip shape and width were severely affected only at P60
explanation: The structural sequence is age- and row-specific in the complete deletion mouse.
- name: Relative Vestibular Sparing
description: Vestibular function has generally been preserved in assessed DFNB77 families, despite LOXHD1 expression in vestibular hair cells. The Dutch series found normal or mildly increased vestibular reactivity and some cVEMP asymmetry; the Japanese series reported no vertigo and normal formal vestibular testing in six individuals. These findings support relative clinical sparing, without proving a dose-dependent protective mechanism or excluding every vestibular abnormality.
biological_scale: CELLULAR
cell_types:
- preferred_term: vestibular hair cell
term:
id: CL:0000609
label: vestibular hair cell
evidence:
- reference: PMID:29676012
reference_title: Further audiovestibular characterization of DFNB77, caused by deleterious variants in LOXHD1, and investigation into the involvement of Fuchs corneal dystrophy.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: There was no evidence for involvement of the vestibular system.
explanation: The Dutch authors found no disease-related vestibular deficit despite minor variations on some tests.
- reference: PMID:31547530
reference_title: Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: No accompanying symptoms, including vestibular dysfunction, with hearing loss were detected in this study.
explanation: The result concerns the LOXHD1-positive subgroup; six individuals had formal vestibular testing, not all 8,074 screened hearing-loss patients.
- name: Sensorineural Hearing Loss
description: Impaired cochlear hair-cell function produces sensorineural hearing loss. The clinical range includes congenital and later-onset loss, stable and progressive courses, and mild through profound severity. The electrophysiological auditory-neuropathy presentation reported in some children does not by itself establish primary auditory-nerve degeneration.
biological_scale: ORGANISM
downstream:
- target: Sensorineural Hearing Impairment
causal_link_type: DIRECT
- target: Progressive Sensorineural Hearing Impairment
causal_link_type: DIRECT
- target: Prelingual Onset Hearing Loss
causal_link_type: DIRECT
- target: Congenital Sensorineural Hearing Impairment
causal_link_type: DIRECT
- target: High-Frequency Hearing Impairment
causal_link_type: DIRECT
- target: Tinnitus
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- target: Auditory Neuropathy Spectrum Disorder Presentation
causal_link_type: DIRECT
- target: Delayed Speech and Language Development
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:29676012
reference_title: Further audiovestibular characterization of DFNB77, caused by deleterious variants in LOXHD1, and investigation into the involvement of Fuchs corneal dystrophy.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: The hearing phenotype showed high inter- and intrafamilial variation in severity and progression.
explanation: Human DFNB77 families show variable expressivity.
- reference: PMID:31547530
reference_title: Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: This study has revealed that most cases showed progressive HL or congenital deaf and some showed relatively stable HL.
explanation: The Japanese series includes contrasting courses and contains some uncertain genotypes.
phenotypes:
- name: Sensorineural Hearing Impairment
category: Auditory
description: The defining clinical manifestation is sensorineural hearing loss, usually bilateral, with severity ranging from mild to profound.
phenotype_term:
preferred_term: Sensorineural hearing impairment
term:
id: HP:0000407
label: Sensorineural hearing impairment
evidence:
- reference: PMID:29676012
reference_title: Further audiovestibular characterization of DFNB77, caused by deleterious variants in LOXHD1, and investigation into the involvement of Fuchs corneal dystrophy.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: In all subjects, HI was sensorineural and symmetric.
explanation: Clinical findings in the Dutch families.
- reference: PMID:31547530
reference_title: Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Their severity of HL at the point of genetic examination varied from mild to profound
explanation: The Japanese series documents a broad severity range.
frequency: OBLIGATE
- name: Progressive Sensorineural Hearing Impairment
category: Auditory
description: Progression occurs in some families and may be slow or rapid. Congenital non-progressive and relatively stable cases also occur. Serial audiograms from 14 individuals in the Japanese cohort showed variable deterioration rates; ascertainment and uncertain variants in part of that cohort limit generalization.
phenotype_term:
preferred_term: Progressive sensorineural hearing impairment
term:
id: HP:0000408
label: Progressive sensorineural hearing impairment
clinical_course: PROGRESSIVE
evidence:
- reference: PMID:19732867
reference_title: Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: we screened DNA from human families segregating deafness and identified a mutation in LOXHD1, which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL)
explanation: Names the phenotype and its progressive character in the founding human family.
- reference: PMID:31547530
reference_title: Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: To further assess the progression of HL, we evaluated the deterioration of hearing by obtaining serial audiograms from 14 individuals
explanation: Longitudinal audiometry exists; the source reports variable individual deterioration.
- reference: PMID:21465660
reference_title: A deleterious mutation in the LOXHD1 gene causes autosomal recessive hearing loss in Ashkenazi Jews.
supports: REFUTE
evidence_source: HUMAN_CLINICAL
snippet: nine patients of Ashkenazi Jewish origin who had severe-profound congenital non-progressive ARNSHL and benefited from cochlear implants.
explanation: Counterevidence to progression as an obligatory feature.
- name: Prelingual Onset Hearing Loss
category: Auditory
description: Hearing loss frequently begins before speech acquisition, including congenitally. Prelingual onset is broader than congenital onset, and later-onset diagnoses also occur.
phenotype_term:
preferred_term: Prelingual sensorineural hearing impairment
term:
id: HP:0000399
label: Prelingual sensorineural hearing impairment
evidence:
- reference: PMID:36472766
reference_title: Biallelic mutations in pakistani families with autosomal recessive prelingual nonsyndromic hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: We identified eight pathogenic or likely pathogenic mutations in LOXHD1, GJB2, SLC26A4, MYO15A, and TMC1 from six families.
explanation: Places LOXHD1 among the genes solving prelingual-onset DFNB in this cohort, which is the basis for recording an early-onset presentation.
- reference: PMID:31547530
reference_title: Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Patients with LOXHD1 variations mostly showed early onset hearing loss and presented different progression rates.
explanation: The Japanese cohort supports predominantly early onset, but early onset is not synonymous with prelingual onset.
- reference: PMID:34753855
reference_title: 'Diagnostic Yield of Targeted Hearing Loss Gene Panel Sequencing in a Large German Cohort With a Balanced Age Distribution from a Single Diagnostic Center: An Eight-year Study.'
supports: REFUTE
evidence_source: HUMAN_CLINICAL
snippet: Four autosomal-recessive genes demonstrated an association with late hearing loss onset in single cases (TMPRSS3, GJB2, LOXHD1, and SLC26A4).
explanation: 'Refutes prelingual onset as an obligate feature: in an age-balanced cohort LOXHD1 also turned up among the late-onset diagnoses. Recorded against this phenotype rather than omitted, so a reader does not take early onset as a rule-out for late presentation.'
- name: Congenital Sensorineural Hearing Impairment
category: Auditory
description: Congenital loss is documented by neonatal screening and family series; it need not be progressive.
phenotype_term:
preferred_term: Congenital sensorineural hearing impairment
term:
id: HP:0008527
label: Congenital sensorineural hearing impairment
evidence:
- reference: PMID:21465660
reference_title: A deleterious mutation in the LOXHD1 gene causes autosomal recessive hearing loss in Ashkenazi Jews.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: nine patients of Ashkenazi Jewish origin who had severe-profound congenital non-progressive ARNSHL and benefited from cochlear implants.
explanation: Direct clinical evidence for a congenital non-progressive presentation.
- name: High-Frequency Hearing Impairment
category: Auditory
description: Some individuals have predominantly high-frequency hearing loss, while others have flatter audiograms.
phenotype_term:
preferred_term: High-frequency hearing impairment
term:
id: HP:0005101
label: High-frequency hearing impairment
evidence:
- reference: PMID:26973026
reference_title: Clinical characteristics of a Japanese family with hearing loss accompanied by compound heterozygous mutations in LOXHD1.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: The two sisters, who had either mild or severe high-frequency hearing loss
explanation: The Japanese family directly supports high-frequency involvement.
- name: Tinnitus
category: Auditory
description: The Japanese cohort narrative reports tinnitus in six of 21 assessed individuals, while its patient table marks seven individuals positive. This discrepancy and the small ascertained sample prevent a reliable disease-frequency estimate.
phenotype_term:
preferred_term: Tinnitus
term:
id: HP:0000360
label: Tinnitus
evidence:
- reference: PMID:31547530
reference_title: Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: A total of 6 out of 21 patients (28.5%) complained of tinnitus, and none of vertigo.
explanation: The denominator is respondents with this assessment, not all screened hearing-loss patients.
- name: Auditory Neuropathy Spectrum Disorder Presentation
category: Auditory
description: Two sisters had an auditory neuropathy spectrum presentation, with abnormal or absent synchronized brainstem responses despite detectable cochlear microphonics and limited early otoacoustic emissions. Their cousin had residual brainstem waveforms with progressive hearing loss. These electrophysiological findings are consistent with a presynaptic hair-cell disorder but do not establish the site of every lesion or a population frequency.
phenotype_term:
preferred_term: Auditory Neuropathy Pattern
term:
id: HP:0006958
label: Abnormal auditory evoked potentials
evidence:
- reference: PMID:35875410
reference_title: Mutations in LOXHD1 gene can cause auditory neuropathy spectrum disorder.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: All three subjects had evidence of some, albeit few, functioning cochlear hair cells as revealed by the presence of a cochlear microphonic and/or partial otoacoustic emissions early in life.
explanation: Three relatives retained some early cochlear responses; the paper specifically identifies the two sisters as presynaptic ANSD cases.
- reference: PMID:35875410
reference_title: Mutations in LOXHD1 gene can cause auditory neuropathy spectrum disorder.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: To our knowledge, this is the first association between LOXHD1 mutations and ANSD in two patients who have been successfully managed with cochlear implants.
explanation: Establishes the association as novel at the time of reporting and records the management outcome, which is why this presentation matters clinically rather than only descriptively.
- name: Delayed Speech and Language Development
category: Auditory
description: Language delay can accompany early hearing loss and may improve with auditory and language habilitation. This is not evidence of an intrinsic global neurodevelopmental syndrome.
phenotype_term:
preferred_term: Delayed speech and language development
term:
id: HP:0000750
label: Delayed speech and language development
evidence:
- reference: PMID:35875410
reference_title: Mutations in LOXHD1 gene can cause auditory neuropathy spectrum disorder.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: The assessment revealed significant delayed receptive and expressive language skills.
explanation: A language assessment in the younger sister before implantation documented delay; later language development improved.
genetic:
- name: LOXHD1
notes: LOXHD1 encodes a multi-PLAT-domain protein required for hair-cell mechanotransduction. Reported alleles include missense, nonsense, frameshift, canonical splice-site and synonymous splice-altering variants. Variants require assessment of phase, segregation, ancestry-matched frequency and functional evidence; in silico predictions alone do not establish pathogenicity. The recurrent c.4212+1G>A allele occurred on different haplotypes in the Japanese study, supporting recurrent origins rather than a demonstrated single founder. Its reported enrichment in Japanese cases does not establish absence from other populations. Fuchs endothelial corneal dystrophy is not an established consequence of DFNB77 carrier status.
relationship_type: CAUSATIVE
gene_term:
preferred_term: LOXHD1
term:
id: hgnc:26521
label: LOXHD1
evidence:
- reference: PMID:19732867
reference_title: Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Based on the studies in mice, we screened DNA from human families segregating deafness and identified a mutation in LOXHD1, which causes DFNB77
explanation: The gene-disease relationship and, in the same sentence, the mouse-first route by which it was established.
- reference: PMID:34753855
reference_title: 'Diagnostic Yield of Targeted Hearing Loss Gene Panel Sequencing in a Large German Cohort With a Balanced Age Distribution from a Single Diagnostic Center: An Eight-year Study.'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: At the single-gene level, causative variants in GJB2 were the most common cause among autosomal-recessive genes (45%), followed by MYO15A and SLC26A4 (both 10%), TMPRSS3 and LOXHD1 (both 7%).
explanation: Quantifies LOXHD1's share among autosomal recessive diagnoses in an unselected cohort, which is what establishes it as a routine contributor rather than a single-family gene.
- reference: PMID:37441688
reference_title: Systematic review of SLC4A11, ZEB1, LOXHD1, and AGBL1 variants in the development of Fuchs' endothelial corneal dystrophy.
supports: SUPPORT
evidence_source: OTHER
snippet: Our review of reported variants in LOXHD1 with respect to segregation in FECD families and data on LOXHD1 expression in corneal endothelium did not reveal any pathogenic variants.
explanation: The systematic reassessment challenges the proposed Fuchs dystrophy association. This supports keeping that association uncertain rather than treating corneal dystrophy as a DFNB77 manifestation.
variants:
- name: c.4212+1G>A
description: Recurrent splice-donor variant found in nine homozygous and nine compound heterozygous individuals in the 2019 Japanese LOXHD1-variant cohort. Differing haplotypes in six homozygotes favored recurrent origins. The paper also notes this allele in population databases outside Japan.
evidence:
- reference: PMID:31547530
reference_title: Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: A recurrent variant c.4212 + 1G > A, only reported in Japanese patients, was detected in 18 individuals. Haplotype analysis implied that this variation occurred in a mutational hot spot, and that multiple ancestors of Japanese population had this variation.
explanation: The abstract describes the published patient reports then available; population restriction is not established. Haplotype results oppose a simple single-founder assumption.
- name: p.D278Y and p.D1219E compound heterozygous pair
description: Novel compound heterozygous LOXHD1 alleles reported in a Pakistani family with prelingual autosomal recessive nonsyndromic hearing loss. Both are missense changes at conserved residues.
evidence:
- reference: PMID:36472766
reference_title: Biallelic mutations in pakistani families with autosomal recessive prelingual nonsyndromic hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: The compound heterozygous mutations in LOXHD1 ([p.D278Y] + [p.D1219E])
explanation: The abstract explicitly identifies the two LOXHD1 alleles; this does not represent six LOXHD1 families.
- name: p.Arg1572Ter
description: Homozygous nonsense variant in nine Ashkenazi Jewish patients with congenital non-progressive severe-to-profound hearing loss.
evidence:
- reference: PMID:21465660
reference_title: A deleterious mutation in the LOXHD1 gene causes autosomal recessive hearing loss in Ashkenazi Jews.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: a novel homozygous mutation of the LOXHD1 gene resulting in a premature stop codon (R1572X) in nine patients of Ashkenazi Jewish origin
explanation: Direct genotype and clinical association.
- name: c.5934C>T synonymous splice-altering variant
description: A synonymous variant in a Dutch family activated a novel splice donor in a HEK293T minigene assay. The assay supports abnormal splicing rather than an amino-acid substitution mechanism.
evidence:
- reference: PMID:29676012
reference_title: Further audiovestibular characterization of DFNB77, caused by deleterious variants in LOXHD1, and investigation into the involvement of Fuchs corneal dystrophy.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: 'the c.5934C>T variant indeed abolished nor-

mal splicing'
explanation: The source reports altered minigene splicing through a novel donor; the line-break hyphen is preserved from the cached PDF.
- name: p.Arg1494Ter and p.Glu1957Ter compound heterozygous pair
description: Two Japanese siblings with moderate or severe loss had compound heterozygous truncating variants and stable hearing during the reported childhood follow-up.
evidence:
- reference: PMID:25792669
reference_title: Mutations in LOXHD1 gene cause various types and severities of hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: We identified compound heterozygous mutations; c.5869G>T, p.E1957X and c.4480C>T, p.R1494X in LOXHD1 gene in two patients of family number 963.
explanation: Directly identifies the alleles and family.
- name: p.Val1892Phe
description: Reported in trans with c.4212+1G>A in two Japanese sisters. Predicted PLAT-domain distortion and reduced membrane affinity are computational hypotheses, not measured binding defects.
evidence:
- reference: PMID:26973026
reference_title: Clinical characteristics of a Japanese family with hearing loss accompanied by compound heterozygous mutations in LOXHD1.
supports: SUPPORT
evidence_source: COMPUTATIONAL
snippet: Molecular modeling predicted that distorted structure of the PLAT domain in the p.V1892F mutant could lead to decreased affinity of the protein to lipid membrane resulting in hair cell dysfunction.
explanation: SWISS-MODEL prediction; a direct lipid-binding defect was not measured.
prevalence:
- population: Japanese hearing-loss patients screened by massively parallel sequencing
measure_type: UNKNOWN
prevalence_class: UNKNOWN
notes: The 2019 study identified 28 affected individuals from 25 families carrying LOXHD1 variants among 8,074 Japanese hearing-loss patients. This is an ascertained cohort, not a population prevalence estimate. Some variants were uncertain, segregation was incomplete in some families, and the authors questioned two relatively frequent missense alleles; 28 is therefore not an unqualified count of definitively solved probands.
evidence:
- reference: PMID:31547530
reference_title: Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: In this study, genetic screening was conducted on 8074 Japanese hearing loss patients utilizing massively parallel DNA sequencing to identify individuals with LOXHD1 variants and to assess their phenotypes. A total of 28 affected individuals and 21 LOXHD1 variants were identified, among which 13 were novel variants.
explanation: Screening denominator and reported LOXHD1-positive group; read alongside the study limitations on pathogenicity and phase.
- population: Hearing-impaired probands, age-balanced German diagnostic cohort
measure_type: UNKNOWN
prevalence_class: UNKNOWN
notes: LOXHD1 accounted for three of 75 molecular diagnoses in a German diagnostic series of 305 hearing-impaired probands. The reported 7% refers to its share among autosomal recessive diagnoses, not population prevalence.
evidence:
- reference: PMID:34753855
reference_title: 'Diagnostic Yield of Targeted Hearing Loss Gene Panel Sequencing in a Large German Cohort With a Balanced Age Distribution from a Single Diagnostic Center: An Eight-year Study.'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: A genetic diagnosis was established for 75 (25%) of the probands that involved 75 causal variants in 35 genes, including 16 novel causal variants and 9 medically significant variant reclassifications.
explanation: The denominator for the yield figure - 25% of 305 probands solved.
- reference: PMID:34753855
reference_title: 'Diagnostic Yield of Targeted Hearing Loss Gene Panel Sequencing in a Large German Cohort With a Balanced Age Distribution from a Single Diagnostic Center: An Eight-year Study.'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Nearly one-quarter of the cases (23%; n = 17) were associated with variants in seven additional genes (TMPRSS3, COL4A3, LOXHD1, EDNRB, MYO6, TECTA, and USH2A).
explanation: Places LOXHD1 in the second tier of contributing genes in that cohort.
- reference: PMID:34753855
reference_title: 'Diagnostic Yield of Targeted Hearing Loss Gene Panel Sequencing in a Large German Cohort With a Balanced Age Distribution from a Single Diagnostic Center: An Eight-year Study.'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: TMPRSS3, COL4A3, and LOXHD1 (each 4%; n = 3)
explanation: The gene-specific count is three of 75 solved cases.
progression:
- phase: Onset
age_range: prelingual to late onset
notes: Onset ranges from congenital to later life in published cohorts. Delayed diagnosis does not necessarily establish delayed biological onset; a passed newborn screen followed by loss is more informative than absence of neonatal testing.
evidence:
- reference: PMID:34753855
reference_title: 'Diagnostic Yield of Targeted Hearing Loss Gene Panel Sequencing in a Large German Cohort With a Balanced Age Distribution from a Single Diagnostic Center: An Eight-year Study.'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Four autosomal-recessive genes demonstrated an association with late hearing loss onset in single cases (TMPRSS3, GJB2, LOXHD1, and SLC26A4).
explanation: The late-onset end of the reported range.
- phase: Established disease
notes: Both stable and progressive courses occur. The Japanese cohort obtained serial audiograms in 14 individuals and reported deterioration rates of 0.1 to 9.3 dB/year in pure-tone average. These rates describe that observed subset rather than a universal trajectory. The Dutch series also analyzed longitudinal audiograms and found both stable and progressive hearing loss.
evidence:
- reference: PMID:31547530
reference_title: Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: 'The deterioration rate varied from 0.1 dB/year to 9.3 dB/year in PTA (mean rate: 3.5 dB/year).'
explanation: Serial audiograms were available for 14 individuals; cohort selection and variant uncertainty limit generalization.
- reference: PMID:25792669
reference_title: Mutations in LOXHD1 gene cause various types and severities of hearing loss.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: His hearing was unchanged from 6 to 9 years old.
explanation: A child with compound heterozygous truncating variants had stable measured hearing over this interval.
diagnosis:
- name: Hearing Loss Gene Panel or Exome Sequencing
description: Molecular diagnosis uses a hearing-loss multigene panel or genomic testing, with assessment of variant pathogenicity, biallelic phase and segregation. The phenotype overlaps other genetic hearing losses. Panel yield depends on cohort selection and test coverage; the German study does not establish that a panel is always sufficient for DFNB77.
evidence:
- reference: PMID:34753855
reference_title: 'Diagnostic Yield of Targeted Hearing Loss Gene Panel Sequencing in a Large German Cohort With a Balanced Age Distribution from a Single Diagnostic Center: An Eight-year Study.'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: A positive family history of autosomal-recessive inheritance in combination with early onset and higher grades of hearing loss significantly increased the solve rate up to 60%, while late onset and lower grades of hearing loss yielded significantly fewer diagnoses.
explanation: The reported solve rate applies to a selected subgroup across hearing-loss genes, not a DFNB77-specific diagnostic sensitivity.
- reference: PMID:34753855
reference_title: 'Diagnostic Yield of Targeted Hearing Loss Gene Panel Sequencing in a Large German Cohort With a Balanced Age Distribution from a Single Diagnostic Center: An Eight-year Study.'
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Targeted hearing loss gene panel analysis proved to be an effective tool for ensuring an appropriate diagnostic yield in a routine clinical setting including the identification of novel variants and medically significant reclassifications.
explanation: Supports panel sequencing as the routine diagnostic modality for this class of disease.
- reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1434/
reference_title: Genetic Hearing Loss Overview - GeneReviews® - NCBI Bookshelf
supports: SUPPORT
evidence_source: OTHER
snippet: The identification of variant(s) of ... uncertain significance ... cannot be used to confirm or rule out the diagnosis.
explanation: A pair of uncertain LOXHD1 variants is not equivalent to a confirmed molecular diagnosis.
- reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1434/
reference_title: Genetic Hearing Loss Overview - GeneReviews® - NCBI Bookshelf
supports: SUPPORT
evidence_source: OTHER
snippet: A multigene hearing loss panel ... can often identify the cause of genetic hearing loss while limiting identification of pathogenic variants and variants of ... uncertain significance ... in genes that are irrelevant to the underlying
explanation: General genetic hearing-loss guidance supports panel-based testing; genomic testing is an alternative depending on the clinical setting.
- name: Audiological Testing Including Otoacoustic Emissions and Cochlear Microphonic
description: Audiometry, otoacoustic emissions, auditory brainstem responses and cochlear microphonic assessment characterize the hearing phenotype. Testing for preserved cochlear responses alongside disordered brainstem responses can identify an auditory-neuropathy pattern. Serial audiometry assesses progression without assuming that every patient will deteriorate.
evidence:
- reference: PMID:35875410
reference_title: Mutations in LOXHD1 gene can cause auditory neuropathy spectrum disorder.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: They were assessed with a standard clinical test battery including distortion otoacoustic emissions, auditory brainstem responses and audiometry.
explanation: The test battery used, and the one that made the ANSD presentation visible.
treatments:
- name: Hearing Aid Amplification
description: Hearing aids provide amplification when residual hearing permits useful benefit. Fitting and follow-up should assess aided hearing and language development. In a reported LOXHD1 family, the cousin had aided thresholds in the mild range but persistent language delay, while two sisters had limited benefit and proceeded to cochlear implantation.
therapeutic_modality: DEVICE
treatment_term:
preferred_term: hearing aid amplification
term:
id: NCIT:C15315
label: Rehabilitation
qualifiers:
- predicate:
preferred_term: medical device
term:
id: NCIT:C16830
label: Medical Device
value:
preferred_term: hearing aid
term:
id: NCIT:C183182
label: Hearing Aid
target_mechanisms:
- target: Sensorineural Hearing Loss
description: Improves access to sound without correcting the underlying mechanotransduction defect.
evidence:
- reference: PMID:35875410
reference_title: Mutations in LOXHD1 gene can cause auditory neuropathy spectrum disorder.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: The cousin proband was fitted with hearing aids at 6 months of age.
explanation: The cousin received amplification; aided thresholds and speech reception improved, but language remained delayed.
- reference: PMID:35875410
reference_title: Mutations in LOXHD1 gene can cause auditory neuropathy spectrum disorder.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Although still delayed, he is currently making progress in terms of speech and language development and remains closely followed with a cochlear implant candidacy evaluation pending on the rate of language development and potential worsening of his hearing loss.
explanation: An aided audiogram alone did not establish adequate language access; ongoing assessment was required.
- reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1434/
reference_title: Genetic Hearing Loss Overview - GeneReviews® - NCBI Bookshelf
supports: SUPPORT
evidence_source: OTHER
snippet: Hearing aids (sound amplification), ... customized by an audiologist to the degree and frequency of hearing loss, can be used in individuals with mild-to-severe hearing loss.
explanation: General genetic hearing-loss guidance supports individualized amplification, not a DFNB77-specific response rate.
- name: Cochlear Implantation
description: Cochlear implantation can provide useful auditory and language outcomes in selected individuals with severe-to-profound LOXHD1-associated hearing loss. Benefit is reported in an Ashkenazi Jewish series, four assessed Japanese recipients, and two sisters with an auditory-neuropathy presentation. These small observational reports do not establish a universal response rate or a genotype-specific optimal implantation age.
therapeutic_modality: DEVICE
treatment_term:
preferred_term: cochlear device implantation
term:
id: NCIT:C15329
label: Surgical Procedure
qualifiers:
- predicate:
preferred_term: medical device
term:
id: NCIT:C16830
label: Medical Device
value:
preferred_term: cochlear implant
term:
id: NCIT:C157820
label: Cochlear Implant
target_mechanisms:
- target: Reduced Hair-Cell Mechanotransduction
description: Electrical stimulation bypasses impaired hair-cell mechanotransduction. Secondary spiral-ganglion degeneration in mouse models does not establish a human timing threshold for implantation.
evidence:
- reference: PMID:35875410
reference_title: Mutations in LOXHD1 gene can cause auditory neuropathy spectrum disorder.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: To our knowledge, this is the first association between LOXHD1 mutations and ANSD in two patients who have been successfully managed with cochlear implants.
explanation: The reported outcome. Two patients is a small basis, and the entry does not present this as an established outcome rate for DFNB77 - only that implantation succeeded where it was tried and reported.
- reference: PMID:21465660
reference_title: A deleterious mutation in the LOXHD1 gene causes autosomal recessive hearing loss in Ashkenazi Jews.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: nine patients of Ashkenazi Jewish origin who had severe-profound congenital non-progressive ARNSHL and benefited from cochlear implants.
explanation: The original clinical report supplies independent evidence of benefit.
- reference: PMID:31547530
reference_title: Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: all four cases for which we were able to obtain the results of the Japanese monosyllable word and sentence perception tests, showed over 90% correctness.
explanation: Four of eight implant recipients had assessed outcomes; the paper reports these results six months after surgery. The full variant cohort includes uncertain genotypes.
- reference: PMID:35875410
reference_title: Mutations in LOXHD1 gene can cause auditory neuropathy spectrum disorder.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: A speech language evaluation at 2 years (16 months after CIs) demonstrated age appropriate receptive and expressive language skills.
explanation: The younger implanted sister had age-appropriate language at this follow-up.
- name: Genetic Counseling
description: Counseling addresses autosomal recessive inheritance, variant classification and phase, reproductive options, and the variable hearing-loss course. When both parents carry the relevant pathogenic LOXHD1 alleles, each pregnancy has a 25% chance of an affected child. Congenital stable and progressive courses are both documented; genotype alone does not reliably predict an individual trajectory.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: Genetic Counseling
term:
id: NCIT:C15240
label: Genetic Counseling
evidence:
- reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1434/
reference_title: Genetic Hearing Loss Overview - GeneReviews® - NCBI Bookshelf
supports: SUPPORT
evidence_source: OTHER
snippet: If both parents are known to be ... heterozygous ... autosomal recessive ... hearing loss-related ... pathogenic variant ... has at conception a 25% chance of having hearing loss
explanation: General Mendelian counseling applies to confirmed biallelic DFNB77 when the parental carrier genotypes are established.
- reference: PMID:21465660
reference_title: A deleterious mutation in the LOXHD1 gene causes autosomal recessive hearing loss in Ashkenazi Jews.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: nine patients of Ashkenazi Jewish origin who had severe-profound congenital non-progressive ARNSHL and benefited from cochlear implants.
explanation: Counseling must include the possibility of non-progressive hearing loss.
- name: Speech, Language and Communication Support
description: Early, individualized language and communication support accompanies audiologic care. Speech-language services, educational accommodations and D/deaf and hard-of-hearing resources should be adapted to the child and family. Hearing thresholds alone do not establish language development.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: speech and language therapy
term:
id: NCIT:C159273
label: Speech Language Therapy
target_mechanisms:
- target: Delayed Speech and Language Development
description: Supports language access and development alongside auditory rehabilitation.
evidence:
- reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1434/
reference_title: Genetic Hearing Loss Overview - GeneReviews® - NCBI Bookshelf
supports: SUPPORT
evidence_source: OTHER
snippet: A speech-language therapist as well as a neuropsychologist/psychologist for children with hearing loss provides access to resources within the community to aid in speech and language and D/deaf and hard of hearing (DHH) identity development.
explanation: General hearing-loss guidance supports language and communication services; no controlled DFNB77-specific intervention trial is implied.
animal_models:
- name: samba mouse (ENU-induced Loxhd1 mutant)
species: Mouse
genotype: Homozygous Loxhd1 samba p.Ile1342Asn (PLAT10)
publication: PMID:19732867
description: ENU-induced mouse allele that helped identify LOXHD1-related human hearing loss. It models loss of hair-cell function followed by degeneration, with allele-specific timing.
modeled_mechanisms:
- target: Progressive Hair-Cell Degeneration
relationship: RECAPITULATES
fidelity: MODERATE
description: Hair-cell functional impairment precedes degeneration in the mouse. This is informative for the progressive subset of human disease but does not reproduce every congenital or stable clinical presentation.
limitations: A mouse point allele standing in for a range of human variants. The correspondence of a particular human genotype's severity to the samba phenotype has not been established, and the human onset range is wide.
readouts:
- name: Hair-cell survival over age
target: Progressive Hair-Cell Degeneration
direction: DECREASED
interpretation: The mouse temporal sequence supports functional impairment preceding cell loss; the human course is variable.
evidence:
- reference: PMID:19732867
reference_title: Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: Stereociliary development is unaffected in samba mice, but hair cell function is perturbed and hair cells eventually degenerate.
explanation: Reports the histological and functional sequence behind this readout.
evidence:
- reference: PMID:19732867
reference_title: Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: We show that hearing loss in the ethylnitrosourea (ENU)-induced samba mouse line is caused by a mutation in Loxhd1.
explanation: The original abstract identifies the causal Loxhd1 mutation in samba mice.
- name: Loxhd1 PLAT10 samba and T1308X mouse comparison
species: Mouse
genotype: Homozygous samba p.Ile1342Asn or engineered p.T1308X_P1420del
publication: PMID:33707295
description: 'Comparison of an ENU-derived missense allele with an engineered premature-stop/deletion allele. T1308X is not a complete null: nonsense-associated alternative splicing can preserve an open reading frame, and residual hearing is milder in some animals.'
modeled_mechanisms:
- target: Reduced Hair-Cell Mechanotransduction
relationship: MEASURES
fidelity: MODERATE
description: Direct measurements show near-normal first-week inner-hair-cell mechanotransduction currents followed by severe impairment at P11. Gross bundle organization and tip links are preserved at these ages, despite modest shortening of lower stereociliary rows.
limitations: Mouse timing and allele effects cannot be assumed for all human variants. Residual hearing in T1308X animals may reflect alternative splicing; nearby genetic modifiers were not excluded. Maintained Harmonin and LHFPL5 do not establish that all channel components remain normally localized.
readouts:
- name: Mechanotransduction current in inner hair cells at postnatal day 11
target: Reduced Hair-Cell Mechanotransduction
direction: DECREASED
interpretation: The failing step, with a normal first postnatal week as the internal control that dates the onset.
evidence:
- reference: PMID:33707295
reference_title: Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: While mechanotransduction currents in mutant inner hair cells (IHCs) were similar to wild-type levels in the first postnatal week, they were severely affected by postnatal day 11.
explanation: Reports the electrophysiological measurement behind this readout.
- name: Tip-link number and hair-bundle morphology
target: Reduced Hair-Cell Mechanotransduction
direction: UNCHANGED
interpretation: Preserved gross organization and tip-link number argue against their loss as the proximate explanation, while allowing subtle structural changes and molecular mislocalization.
evidence:
- reference: PMID:33707295
reference_title: Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: The mechanotransduction defect observed in Loxhd1-mutant IHCs was not accompanied by a morphologic defect of the hair bundle or a reduction in TL number.
explanation: Reports the structural measurements behind this readout.
- name: Harmonin and LHFPL5 localisation in the hair bundle
target: Reduced Hair-Cell Mechanotransduction
direction: UNCHANGED
interpretation: The localization of these two proteins is maintained. Other components were not adequately assessed in this experiment; the later complete-deletion model demonstrates TMC1 mislocalization.
evidence:
- reference: PMID:33707295
reference_title: Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: we found that two proteins of the upper and lower TL protein complexes (Harmonin and LHFPL5) were maintained in the mutants
explanation: Reports the immunolocalisation measurement behind this readout.
evidence:
- reference: PMID:33707295
reference_title: Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: Here, we identified the hearing loss-associated Loxhd1/DFNB77 gene as being required for the mechanotransduction process.
explanation: Supports treating this model as informative for the transduction node, and names the human locus explicitly.
- reference: PMID:33707295
reference_title: Loxhd1 Mutations Cause Mechanotransduction Defects in Cochlear Hair Cells.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: The NAS surveillance mechanism promotes splicing around the mutated exons and maintains open reading frames
explanation: Nonsense-associated alternative splicing was detected in the T1308X allele; functional attenuation is a proposed interpretation, with genetic background alternatives retained.
- name: Loxhd1 complete-deletion mouse
species: Mouse
genotype: Homozygous Loxhd1Delta deletion removing all 15 PLAT domains
publication: PMID:39256406
description: Large-scale deletion establishes that LOXHD1 maintains TMC1 at the lower tip-link insertion. Remaining TMC1 redistributes along stereociliary shafts, while TMC2 localization is preserved. Inner-hair-cell currents are already reduced at P7 and become more severely impaired at P11.
modeled_mechanisms:
- target: TMC1 Mislocalization from Tip-Link Insertion Sites
relationship: MEASURES
fidelity: MODERATE
description: Large-scale deletion establishes that LOXHD1 maintains TMC1 at the lower tip-link insertion. Remaining TMC1 redistributes along stereociliary shafts, while TMC2 localization is preserved. Inner-hair-cell currents are already reduced at P7 and become more severely impaired at P11.
limitations: This engineered large deletion does not represent the full spectrum of human alleles. Some residual currents remain; mild heterozygote mouse threshold changes do not establish dominant human DFNB77.
evidence:
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: In P21 Loxhd1Delta/Delta IHCs, TMC1 molecules were not confined to stereocilia tips and could instead be found mislocalized along stereocilia shafts.
explanation: Super-resolution localization directly demonstrates displacement of remaining TMC1.
- target: Reduced Hair-Cell Mechanotransduction
relationship: MEASURES
fidelity: MODERATE
description: Direct inner-hair-cell recordings measure reduced currents at P7 and P11 after complete deletion.
limitations: Developmental mouse timing and a complete deletion cannot predict the course of every human allele.
readouts:
- name: Inner-hair-cell mechanotransduction current
target: Reduced Hair-Cell Mechanotransduction
direction: DECREASED
interpretation: Complete deletion impairs currents earlier than PLAT10-limited mutations, with residual activity still present.
evidence:
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: the complete absence of LOXHD1 leads to earlier effects on IHC MET currents at P7 (33% amplitude reduction), which continues to an 84% reduction at P11.
explanation: The comparison defines the allele-specific temporal difference.
evidence:
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: the complete absence of LOXHD1 leads to earlier effects on IHC MET currents at P7 (33% amplitude reduction), which continues to an 84% reduction at P11.
explanation: The comparison defines the allele-specific temporal difference.
- name: LOXHD1-associated hearing loss in Rottweilers
species: Dog
genotype: Homozygous LOXHD1 p.Gly1914Ala
publication: PMID:33983508
description: A naturally occurring recessive missense variant segregated with congenital or early-onset bilateral deafness in Rottweilers. Four affected littermates lacked auditory brainstem responses when tested.
modeled_mechanisms:
- target: Sensorineural Hearing Loss
relationship: MEASURES
fidelity: MODERATE
description: A naturally occurring recessive missense variant segregated with congenital or early-onset bilateral deafness in Rottweilers. Four affected littermates lacked auditory brainstem responses when tested.
limitations: Variant segregation and hearing tests support a large-animal model, but this study did not measure mechanotransduction or hair-cell histology in the genotyped dogs. Histological degeneration described in earlier ungenotyped Rottweilers cannot be attributed definitively to this allele. Progression from partial loss to deafness was inferred from owner reports and remains unconfirmed.
evidence:
- reference: PMID:33983508
reference_title: Missense variant in LOXHD1 is associated with canine nonsyndromic hearing loss.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: We observed complete segregation of the variant with hearing loss, as all four affected dogs were homozygous for the variant.
explanation: The 585-dog cohort included four affected homozygotes; unaffected dogs were heterozygous or wild type.
- reference: PMID:33983508
reference_title: Missense variant in LOXHD1 is associated with canine nonsyndromic hearing loss.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: Sensorineural bilateral deafness was diagnosed in four Rottweiler siblings (one female and three males) in a litter of ten puppies using brainstem auditory evoked response (BAER) testing.
explanation: Direct electrophysiological evidence for the canine hearing phenotype.
discussions:
- discussion_id: dfnb77_no_genotype_phenotype_correlation
kind: KNOWLEDGE_GAP
status: OPEN
prompt: Which allele-specific, splicing, genetic or environmental factors explain variation in DFNB77 onset and course?
attaches_to:
- genetic#LOXHD1
- phenotypes#Progressive Sensorineural Hearing Impairment
- progression#Onset
rationale: The Dutch and Japanese cohorts did not establish a simple relationship between variant class or position and severity or progression. Their limited sample sizes, follow-up differences, uncertain variants and heterogeneous compound genotypes constrain those negative findings. Intrafamilial variation is documented, but no specific human modifier has been established by these studies. Nonsense-associated alternative splicing was proposed to attenuate a mouse allele and is a candidate mechanism to test in human variants, not a demonstrated explanation for human variability.
evidence:
- reference: PMID:29676012
reference_title: Further audiovestibular characterization of DFNB77, caused by deleterious variants in LOXHD1, and investigation into the involvement of Fuchs corneal dystrophy.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: a clear correlation between the type or location of the variant and the severity or progression of HI could not be established. We hypothesize that environmental factors or genetic modifiers are responsible for phenotypic differences.
explanation: The cohort found no clear correlation; environmental and genetic modifiers remain hypotheses.
- reference: PMID:31547530
reference_title: Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: Patients with LOXHD1 variations mostly showed early onset hearing loss and presented different progression rates. We speculated that the varying severities and progression rates of hearing loss are the result of environmental and/or other genetic factors.
explanation: The Japanese variant cohort also showed variable progression, but did not test specific modifiers.
proposed_experiments:
- experiment_id: exp_dfnb77_modifier_and_exposure_study
name: Modifier and noise-exposure study in the Japanese c.4212+1G>A cohort
description: Study longitudinal hearing in individuals carrying c.4212+1G>A while explicitly accounting for the second allele, phase, age, treatment and follow-up. Test transcript consequences, candidate genetic modifiers and measured exposures using adequate comparison groups. Sharing one allele does not hold the whole genotype constant.
would_support:
- genetic#LOXHD1
supporting_outcome:
- Progression rate tracks a modifier locus or a measured exposure, converting an unexplained variance into a counselling-relevant and potentially modifiable factor.
refuting_outcome:
- No association would limit the tested hypotheses at the available power; it would not establish stochastic causation or the impossibility of prognosis.
- discussion_id: dfnb77_how_loxhd1_gates_transduction
kind: KNOWLEDGE_GAP
status: OPEN
prompt: Which LOXHD1 interfaces and lipid interactions stabilize the TMC1-tip-link connection, and can restoring that connection recover mature hair-cell function?
attaches_to:
- pathophysiology#LOXHD1 Loss of Function in Stereocilia
- pathophysiology#Reduced Hair-Cell Mechanotransduction
rationale: The 2024 deletion and tagged-protein experiments establish that LOXHD1 maintains TMC1 near the lower tip-link insertion. Earlier preservation of Harmonin and LHFPL5 did not establish normal localization of every mechanotransduction component. Co-immunoprecipitation supports associations with TMC1, CIB2, LHFPL5 and PCDH15, but exact direct-binding interfaces and the contribution of membrane lipids remain unresolved. The p.Val1892Phe lipid-affinity proposal remains computational. Persistence of some mislocalized TMC1 motivates rescue experiments; a therapeutic window and effective gene replacement have not been demonstrated by these localization studies.
evidence:
- reference: PMID:39256406
reference_title: LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
supports: SUPPORT
evidence_source: OTHER
snippet: The interaction between LOXHD1 and PCDH15 could occur through direct binding, indirect mediation via LHFPL5, or a combination of both mechanisms.
explanation: The interaction topology remains a stated limitation of the proposed stabilizing model.
- reference: PMID:26973026
reference_title: Clinical characteristics of a Japanese family with hearing loss accompanied by compound heterozygous mutations in LOXHD1.
supports: SUPPORT
evidence_source: COMPUTATIONAL
snippet: Molecular modeling predicted that distorted structure of the PLAT domain in the p.V1892F mutant could lead to decreased affinity of the protein to lipid membrane resulting in hair cell dysfunction.
explanation: The one LOXHD1-specific prediction of a lipid-binding role, which is why this gap is described as lacking an experimental test rather than lacking a hypothesis. Graded COMPUTATIONAL, and the authors' hedge "could lead to" is kept in the quote.
proposed_experiments:
- experiment_id: exp_dfnb77_loxhd1_interactome_and_lipid_binding
name: Map LOXHD1 interaction interfaces and test functional rescue
description: Map individual PLAT-repeat protein and lipid interactions, then compare wild-type and disease-associated constructs in biochemical assays and Loxhd1-null hair cells. Measure TMC1 tip localization, MET currents and bundle survival after timed re-expression.
would_support:
- pathophysiology#Reduced Hair-Cell Mechanotransduction
supporting_outcome:
- Restored LOXHD1-dependent TMC1 positioning is accompanied by recovery of mechanotransduction, identifying a functional interaction and an experimentally supported rescue interval.
refuting_outcome:
- Restoring localization fails to restore currents, or particular binding-deficient constructs retain function, limiting the proposed mechanism. Negative results require adequate expression and assay sensitivity before excluding a role.
references:
- reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1434/
title: Genetic Hearing Loss Overview - GeneReviews® - NCBI Bookshelf
tags:
- GeneReviews

📚

References & Deep Research

References

1

url:https://www.ncbi.nlm.nih.gov/books/NBK1434/

Genetic Hearing Loss Overview - GeneReviews® - NCBI Bookshelf

No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Create: Autosomal Recessive Nonsyndromic Hearing Loss 77 (DFNB77, LOXHD1) · 2026-08-30T21:41:25Z · View source

De-novo curation of DFNB77 (MONDO:0013119, LOXHD1) from an OpenScientist deep-research report plus primary literature. Modelled the chain: LOXHD1 loss of function in stereocilia, hair-cell mechanotransduction failure with intact bundle architecture, progressive hair-cell degeneration, progressive sensorineural hearing loss. The mechanism node is defined as much by exclusions as by the positive result: bundle morphology, tip-link number and tip-link complex protein localisation were all measured and normal, which is what supports the authors' reading that the machinery is present but not activatable. Curated two negative findings from cohort studies, vestibular sparing and the absent genotype-phenotype correlation, and recorded in the entry that the schema has no EXCLUDED frequency value to express the first properly (issue #10190). Two mouse models with explicit relationship types, including the samba line by which the human gene was found. Two discussions filed. preflight-dr returned WARN on a false-positive rival-gene call, PLAT being the protein domain rather than the gene; the report is on topic. Validated with just validate, just validate-terms, just validate-disorders, just check-entity-refs, just check-duplicate-keys, just check-snippet-grading and just check-folded-hyphens.

OpenScientist ▸

Key Findings

openscientist-autonomous 8 citations 2026-08-30T21:35:23.583974

Key Findings

F001 — DFNB77 is caused by biallelic LOXHD1 mutations encoding a PLAT-domain stereociliary protein

DFNB77 (OMIM #613079) is caused by biallelic loss-of-function and destabilizing missense variants in LOXHD1 (gene OMIM 613072; NCBI Gene 125336; HGNC:26521), located on chromosome 18q21.1. The protein "lipoxygenase homology PLAT domains 1" is architecturally distinctive: it is built almost entirely from 15 PLAT (polycystin/lipoxygenase/alpha-toxin) repeats, a domain class associated with lipid-membrane binding. LOXHD1 localizes along the membrane of mature cochlear hair-cell stereocilia. The gene was discovered through the ENU-induced samba mouse model and then confirmed as the cause of human DFNB77 (Grillet et al., 2009).

"LOXHD1 consists entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains and is expressed along the membrane of mature hair cell stereocilia." — PMID: 19732867

"we screened DNA from human families segregating deafness and identified a mutation in LOXHD1, which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL)" — PMID: 19732867

Ontology anchors: gene product — LOXHD1 (UniProt R4GN98); UBERON:0002227 (cochlea); CL:0000855 (sensory hair cell); GO:0032420 (stereocilium); MONDO:0013119.

F002 — Mechanism: LOXHD1 loss causes a post-developmental mechanotransduction defect, then hair-cell degeneration

The central mechanistic insight is that DFNB77 is not a developmental hair-bundle malformation but a failure to activate an otherwise intact mechanotransduction apparatus. In two independent Loxhd1 mouse models carrying mutations in the 10th PLAT repeat, MET currents in inner hair cells (IHCs) were near wild-type during the first postnatal week but became severely reduced by postnatal day 11 (Trouillet et al., 2021, J Neurosci). Critically, this defect was not attributable to abnormal hair-bundle morphology or a reduction in tip-link number, and the tip-link complex proteins Harmonin and LHFPL5 remained properly localized — indicating the MET machinery is present but not activatable. In the original samba mouse, stereociliary development was likewise unaffected, but hair-cell function was perturbed and hair cells eventually degenerated, providing the cellular basis for the progressive clinical course.

"While mechanotransduction currents in mutant inner hair cells (IHCs) were similar to wild-type levels in the first postnatal week, they were severely affected by postnatal day 11." — PMID: 33707295

"two proteins of the upper and lower TL protein complexes (Harmonin and LHFPL5) were maintained in the mutants, suggesting that the mechanotransduction machinery was present but not activatable" — PMID: 33707295

"Stereociliary development is unaffected in samba mice, but hair cell function is perturbed and hair cells eventually degenerate." — PMID: 19732867

Ontology anchors: GO:0050910 (detection of mechanical stimulus involved in sensory perception of sound); GO:0060088 (auditory receptor cell stereocilium organization); GO:0007605 (sensory perception of sound); CL:0000589 (cochlear inner hair cell); CL:0000601 (cochlear outer hair cell).

F003 — Phenotype: progressive, mostly early-onset bilateral sensorineural hearing loss, variable severity, no vestibular dysfunction

Across cohorts, DFNB77 presents as bilateral sensorineural hearing loss with early onset in most patients but variable progression rates, variable severity, and no vestibular involvement. In the largest reported cohort (8,074 Japanese hearing-loss patients; Maekawa et al., 2019), 28 affected individuals carried LOXHD1 variants; these patients mostly showed early-onset hearing loss with differing progression rates, and no accompanying symptoms — including vestibular dysfunction — were detected. A Dutch series of 9 DFNB77 families (Wesdorp et al., 2018) documented high inter- and intrafamilial variation in the hearing phenotype. Minami et al. (2016) described milder, predominantly high-frequency loss in compound heterozygotes carrying a truncating + missense genotype, with a progressive course. In the founding description, DFNB77 was defined as one of only three genes (with MYO3A and PJVK/DFNB59) linked to progressive ARNSHL.

"Patients with LOXHD1 variations mostly showed early onset hearing loss and presented different progression rates." — PMID: 31547530

"No accompanying symptoms, including vestibular dysfunction, with hearing loss were detected in this study." — PMID: 31547530

"These cases showed less severe hearing impairment than the previously reported cases carrying LOXHD1 mutations, but their hearing loss appeared to be progressive." — PMID: 26973026

Suggested HPO terms:

HPO term	Label	Notes
HP:0000407	Sensorineural hearing impairment	Core phenotype
HP:0008527	Congenital sensorineural hearing impairment	Early/congenital-onset subset
HP:0000408	Progressive sensorineural hearing impairment	Progressive course
HP:0008550	High-frequency hearing impairment	High-frequency predominance in some genotypes
HP:0000365	Hearing impairment	General
HP:0000359	Abnormality of the inner ear	Cochlear localization

Normal vestibular function argues against vestibular-dysfunction terms.

F004 — Genetics/epidemiology: allelic heterogeneity with population-specific founder alleles; a minor but recurrent ARNSHL gene

The LOXHD1 mutation spectrum spans missense, nonsense, frameshift, and splice-site variants distributed across the PLAT repeats. A recurrent splice variant, c.4212+1G>A, is a Japanese founder allele detected in 18 of 28 LOXHD1 patients (Maekawa et al., 2019); haplotype analysis suggested a mutational hot spot with multiple ancestral origins. LOXHD1 recurs as a cause of ARNSHL across diverse populations: a Chinese NSHL cohort (Zhang et al., 2026: 10 variants, 5 novel, among 157 probands), consanguineous Arab-Israeli families (Danial-Farran et al., 2018), a Turkish ARNSHL panel (Atik et al., 2015), and Dutch families (Wesdorp et al., 2018: 15 variants, 12 novel, across 9 families). Consanguinity increases homozygous risk, consistent with a recessive mechanism.

"we identified ten different variants in the LOXHD1 gene from five patients in their families" — PMID: 42131115

"deafness was explained by damaging alleles of SLC26A4, MYO15A, OTOG, LOXHD1, and TBC1D24" — PMID: 30139988

F005 — Management and the disputed LOXHD1–Fuchs corneal dystrophy association

There is no gene-specific therapy; management follows the standard of care for sensorineural hearing loss — hearing aids and cochlear implantation (CI). Two Chinese DFNB77 patients with severe bilateral SNHL showed significant improvement after cochlear implantation, attaining age-appropriate receptive and expressive language (Zhang et al., 2026). Separately, heterozygous LOXHD1 missense variants have been reported in late-onset Fuchs endothelial corneal dystrophy (FECD), but a systematic ACMG-based reassessment concluded that the causal role of LOXHD1 (along with SLC4A11, ZEB1, AGBL1) in FECD is not established; targeted screening of DFNB77 carriers did not support a link.

"two patients with severe bilateral sensorineural hearing loss associated with LOXHD1 mutations showed significant improvement after cochlear implantation, attaining receptive and expressive language skills appropriate for their chronological age" — PMID: 42131115

"The causal role of other genes, SLC4A11, ZEB1, LOXHD1, and AGBL1, which have been reported to be associated with FECD, is more complicated and less obvious." — PMID: 37441688

Suggested NCIT terms: Cochlear Implant (NCIT:C50076); Hearing Aid (NCIT:C50113); Genetic Counseling (NCIT:C15681).

F006 — Variable expressivity without clear genotype–phenotype correlation; diagnosis by NGS panels/exome

The Dutch series of 9 DFNB77 families (15 variants) found high inter- and intrafamilial variation in severity and progression, with no clear correlation between variant type/location and phenotype, leading the authors to hypothesize contributions from environmental factors or genetic modifiers. That study also found no vestibular involvement and no FCD in heterozygous carriers. Minami et al. (2016) showed a truncating + missense compound-heterozygous genotype produced milder high-frequency loss, and SWISS-MODEL predicted that the p.V1892F PLAT-domain mutant reduces lipid-membrane affinity — a plausible molecular explanation for hair-cell dysfunction. Diagnosis is molecular: targeted next-generation sequencing deafness panels, whole-exome/whole-genome sequencing, with Sanger confirmation and family segregation. Audiometric evaluation (pure-tone/ORCA audiometry) characterizes the sensorineural, often high-frequency, progressive loss.

"The hearing phenotype showed high inter- and intrafamilial variation in severity and progression." — PMID: 29676012

"a clear correlation between the type or location of the variant and the severity or progression of HI could not be established" — PMID: 29676012

"No association was found between heterozygous LOXHD1 variants and the occurrence of FCD in carriers." — PMID: 29676012

"distorted structure of the PLAT domain in the p.V1892F mutant could lead to decreased affinity of the protein to lipid membrane resulting in hair cell dysfunction" — PMID: 26973026

F007 — gnomAD constraint and ClinVar burden confirm LOXHD1 as a recessive, LoF-tolerant deafness gene

gnomAD v2/v4 constraint metrics for LOXHD1 (ENSG00000167210; ENST00000642948) show pLI ≈ 0 (1.8e-56) and an observed/expected loss-of-function ratio oe_lof = 0.826 (90% CI 0.737–0.927; LOEUF ≈ 0.93), with lof_z = 2.33 and mis_z = 0.33. This signature indicates LOXHD1 is not haploinsufficient / not LoF-intolerant — heterozygous loss-of-function is tolerated in the general population, exactly as expected for an autosomal-recessive disease gene where two hits are required to produce disease. ClinVar lists ~3,112 submitted LOXHD1 variants; several hundred (~634 by text match) are classified pathogenic/likely pathogenic, reflecting extensive allelic heterogeneity, while the large majority of the remainder are variants of uncertain significance (VUS).

Constraint metric	Value	Interpretation
pLI	≈ 0 (1.8e-56)	Not haploinsufficient
oe_lof (LOEUF)	0.826 (90% CI 0.737–0.927) ≈ 0.93	LoF-tolerant
lof_z	2.33	Mild LoF constraint only
mis_z	0.33	Missense unconstrained
ClinVar P/LP	~634 of ~3,112	Extensive allelic heterogeneity

F008 — gnomAD-derived estimate: pLoF carrier frequency ~0.5%, predicted biallelic-LoF prevalence ~6.5 per million (lower bound)

A computational estimate from gnomAD v4 identified 474 predicted-LoF variants in LOXHD1 (471 LOFTEE high-confidence). The summed pLoF allele frequency q ≈ 0.00255 (0.25%). Under Hardy–Weinberg equilibrium, the carrier frequency 2q(1−q) ≈ 0.51% (~1 in 197), and the predicted biallelic (homozygous + compound-heterozygous) LoF birth prevalence q² ≈ 6.5 × 10⁻⁶ (~1 in 154,000). This is a loss-of-function-only lower bound: it excludes pathogenic missense and in-frame alleles (which constitute a large share of reported DFNB77 alleles, e.g., p.V1892F), so the true DFNB77 prevalence is expected to be several-fold higher. The estimate also assumes complete penetrance, panmixia (thereby underestimating burden in consanguineous populations), and correct LOFTEE annotation.

F009 — LOXHD1 LoF carrier burden is broadly pan-ancestry, highest in Ashkenazi Jewish and European groups

Ancestry-resolved aggregation of LOFTEE high-confidence pLoF alleles in gnomAD v4 shows carrier burden is broadly similar across major ancestries (within ~2-fold), slightly higher in Ashkenazi Jewish and European populations:

Ancestry	Carrier freq 2q(1−q)	~1 in N
Ashkenazi Jewish (q≈0.0035)	~0.70%	~143
Admixed American	~0.56%	~180
African / African-American	~0.56%	~180
Non-Finnish European (AN>1M)	~0.55%	~182
East Asian	~0.47%	~215
Finnish	~0.42%	~238
South Asian	~0.39%	~256
Middle Eastern (AN≈5,700)	~0.32%	~313
Amish (AN≈912)	0	—

Full Section-by-Section Report

1. Disease Information

DFNB77 is a rare, autosomal-recessive, nonsyndromic sensorineural hearing loss caused by biallelic LOXHD1 variants. Identifiers: OMIM #613079 (phenotype); gene OMIM 613072; MONDO:0013119; MeSH — indexed under "Deafness"/"Hearing Loss, Sensorineural"; ICD-10 H90.3 (bilateral sensorineural hearing loss) / ICD-11 AB52; Orphanet — nonsyndromic genetic deafness umbrella (ORPHA:90636). Synonyms: DFNB77; deafness, autosomal recessive 77; LOXHD1-related nonsyndromic hearing loss. Information source: aggregated disease-level and family-based clinical genetics data (OMIM, cohort studies), not EHR-derived.

2. Etiology

Causal factor: monogenic — biallelic pathogenic LOXHD1 variants. Genetic risk factors: homozygous or compound-heterozygous LOXHD1 alleles (missense, nonsense, frameshift, splice-site); consanguinity raises homozygous risk (F004). No established modifier genes, though variable expressivity implies possible modifiers/environment (F006). Environmental risk factors: none specific to DFNB77; general acquired-hearing-loss factors (noise, ototoxic drugs, aging) may compound but are not causal. Protective factors: none identified. Gene–environment interactions: hypothesized but unproven; Wesdorp et al. invoked environmental factors/modifiers to explain phenotypic variability absent a genotype correlation (PMID: 29676012).

3. Phenotypes

Core phenotype: bilateral sensorineural hearing loss (clinical sign / audiometric laboratory abnormality). Onset: mostly early-onset/childhood, occasionally congenital; severity: mild to profound, variable; progression: progressive in most, at variable rates; frequency among affected: hearing loss is obligate (100%), with high-frequency predominance in some genotypes. No vestibular dysfunction and no syndromic features (F003). Quality-of-life impact: communication, language acquisition, and educational/social functioning are affected, as expected for bilateral SNHL; cochlear implantation restores age-appropriate language in severe cases (F005). HPO terms per F003 (HP:0000407, HP:0000408, HP:0008527, HP:0008550).

4. Genetic/Molecular Information

Causal gene: LOXHD1 (18q21.1; HGNC:26521; NCBI Gene 125336; gene OMIM 613072). Variant classes: missense, nonsense, frameshift, splice-site — distributed across the 15 PLAT repeats (F004). Notable alleles: c.4212+1G>A (Japanese founder splice variant, 18/28 patients); p.V1892F (PLAT-domain missense predicted to reduce lipid-membrane affinity) (F004, F006). Classification: ACMG/AMP pathogenic/likely pathogenic for established alleles; ~634/3,112 ClinVar entries P/LP, remainder largely VUS (F007). Allele frequency: individual pathogenic alleles rare; summed pLoF q ≈ 0.25% (F008). Origin: germline. Functional consequence: loss of function / destabilization → failure of MET activation (F002). Constraint: LoF-tolerant (LOEUF ≈ 0.93; pLI ≈ 0), consistent with recessive biology (F007). Modifier genes / epigenetics / chromosomal abnormalities: none established.

5. Environmental Information

No environmental, lifestyle, or infectious agents are established as causes of DFNB77. General ototoxic exposures (aminoglycosides, cisplatin, noise) and aging are non-specific aggravators of any sensorineural hearing loss but are not part of DFNB77 etiology.

6. Mechanism / Pathophysiology

Ordered causal chain:

Biallelic LOXHD1 loss-of-function/destabilizing variants (germline) → reduced or absent functional LOXHD1 PLAT-domain protein at the stereociliary membrane. (demonstrated — F001)
Loss of LOXHD1 → stereocilia and tip links still form and mature normally; MET complex proteins (Harmonin, LHFPL5) remain localized. (demonstrated — F002)
However, the assembled MET machinery cannot be activated → mechanotransduction currents collapse after the first postnatal week (by ~P11 in mouse). (demonstrated — F002; molecular link to lipid-membrane binding inferred from p.V1892F modeling — F006)
Loss of MET current → hair-cell functional failure → deprivation of normal receptor-current activity. (demonstrated)
Chronic dysfunction → progressive hair-cell degeneration (over time). (demonstrated in mouse; inferred as substrate of human progression — F002/F003)
Hair-cell loss → progressive bilateral sensorineural hearing loss, high-frequency predominant, variable severity, vestibular sparing. (clinical — F003)

LOXHD1 biallelic LoF/missense
│
▼
Normal stereocilia + tip links form (Harmonin, LHFPL5 present)
│
▼
MET channel present but NOT activatable  ← p.V1892F ↓ lipid-membrane affinity (inferred)
│
▼
MET current collapses post-development (~P11 mouse)
│
▼
Hair-cell functional failure ──▶ progressive hair-cell degeneration
│
▼
Progressive bilateral SNHL (variable severity, high-freq, vestibular-sparing)

Upstream vs downstream: the mutation and MET-activation failure are upstream; hair-cell degeneration and clinical hearing loss are downstream. Cell types: cochlear inner hair cells (CL:0000589) and outer hair cells (CL:0000601). Biological processes (GO): GO:0050910, GO:0007605, GO:0060088. Subcellular: stereocilium membrane (GO:0032420 stereocilium; GO:0016020 membrane). Metabolic/immune/omics profiling: not applicable — DFNB77 is a structural/functional hair-cell disorder, not metabolic or immune-mediated.

7. Anatomical Structures Affected

Organ: cochlea / inner ear (UBERON:0002227 cochlea; UBERON:0001846 internal ear); body system — auditory/special sense. Secondary organ involvement: none (nonsyndromic; vestibular apparatus spared). Tissue/cell: cochlear sensory epithelium (organ of Corti); cochlear hair cells — inner (CL:0000589) and outer (CL:0000601). Subcellular: stereocilia / stereociliary membrane (GO:0032420). Localization: bilateral; cochlear.

8. Temporal Development

Onset: mostly early-onset/childhood, sometimes congenital; insidious. Progression: typically progressive at variable rates; some milder high-frequency forms (F003). Course: chronic, lifelong, non-remitting. Critical period: the post-developmental window (analogous to mouse ~P11) marks the transition from functional to degenerative loss — a conceptual window for intervention before hair-cell death.

9. Inheritance and Population

Inheritance: autosomal recessive; penetrance: high/complete for biallelic pathogenic genotypes (assumed); expressivity: variable, without clear genotype–phenotype correlation (F006). No anticipation (not a repeat disorder). Founder effects: Japanese c.4212+1G>A (F004). Consanguinity: increases homozygous risk. Carrier frequency (pLoF only): ~0.5% overall; pan-ancestry ~0.3–0.7%, highest in Ashkenazi Jewish (~0.70%) and European (~0.55%) groups (F008, F009). Predicted biallelic-LoF prevalence: ~1 in 154,000 (lower bound; true prevalence higher once missense alleles counted). Sex ratio: ~1:1. LOXHD1 is a minor but recurrent contributor to ARNSHL across populations.

10. Diagnostics

Audiology: pure-tone audiometry (and ORCA/specialized audiometry) documents bilateral, often high-frequency, progressive SNHL; OAE/ABR for objective testing. Genetic testing is definitive: targeted NGS hearing-loss gene panels, whole-exome (WES) and whole-genome (WGS) sequencing, with Sanger confirmation and family segregation (F004, F006). Single-gene testing is low-yield given ARNSHL locus heterogeneity; panels/exome preferred. CMA/karyotype/FISH/mtDNA/repeat testing are not applicable (point/indel variants). Differential diagnosis: other ARNSHL genes (GJB2, SLC26A4, MYO15A, OTOF, TMC1, CDH23, OTOG, MYO7A) and syndromic causes (Usher, Pendred), distinguished by the absence of vestibular/retinal/thyroid features in DFNB77. Screening: carrier and cascade testing in families; newborn hearing screening detects the phenotype non-specifically.

11. Outcome/Prognosis

Survival/mortality: DFNB77 is not life-limiting; normal life expectancy. Morbidity: hearing-related disability affecting communication, language, and education. Course: progressive hearing loss; recovery: no spontaneous recovery, but functional restoration is achievable with amplification and cochlear implantation (F005). Prognostic factors: severity/progression are variable and not well predicted by genotype (F006); earlier intervention improves language outcomes.

12. Treatment

No gene-specific or pharmacological therapy exists. Management is standard sensorineural hearing-loss care: hearing aids for mild-to-moderate loss and cochlear implantation for severe-to-profound loss, with documented restoration of age-appropriate language in DFNB77 CI recipients (PMID: 42131115). Rehabilitative: auditory-verbal/speech therapy, educational support. Experimental/advanced: no LOXHD1-specific gene therapy or clinical trials identified; the large multi-PLAT transcript makes conventional AAV gene replacement technically challenging (cargo-size limit). Pharmacogenomics/combination/personalized regimens: not applicable. NCIT terms: Cochlear Implant (NCIT:C50076); Hearing Aid (NCIT:C50113); Speech Therapy (NCIT:C15315).

13. Prevention

Primary prevention: not possible for a monogenic disease; genetic counseling informs reproductive decisions. Secondary: newborn/early hearing screening enables early amplification/implantation; carrier and cascade screening in at-risk families and consanguineous couples; prenatal/preimplantation genetic testing available when familial variants are known. Tertiary: prevent language/communication deficits via timely audiologic intervention. No immunization or environmental prevention applies.

14. Other Species / Natural Disease

Taxonomy: studied in Mus musculus (NCBI Taxon 10090). Orthologous gene: mouse Loxhd1 (NCBI Gene 240873). Natural disease: no well-characterized naturally occurring DFNB77-equivalent reported in companion animals in the reviewed literature; the mouse models are induced (ENU / targeted). Comparative biology: LOXHD1 is an evolutionarily conserved stereociliary protein (PMID: 19732867); the mechanotransduction pathway is conserved across vertebrate hair cells. Zoonotic/transmission: not applicable.

15. Model Organisms

Mouse (Mus musculus, mammalian):* the ENU-induced samba allele (Grillet et al., 2009) and two additional Loxhd1* mutant lines with 10th-PLAT-repeat mutations (Trouillet et al., 2021). Model types: ENU-induced point mutants and targeted alleles. Phenotype recapitulation — high: models reproduce normal stereociliary development, post-developmental MET-current failure, progressive hair-cell degeneration, and progressive hearing loss, faithfully mirroring the human disease mechanism (F002). Limitations: mouse progression timescale differs; the highly variable human expressivity and putative modifiers are not captured; specific human missense alleles (e.g., p.V1892F) modeled computationally rather than in vivo. Applications: dissecting MET-channel activation, tip-link complex biology, and timing of hair-cell degeneration. Resources: MGI (Loxhd1), IMPC.

Mechanistic Model / Interpretation

DFNB77 is best understood as a "machinery present but not activatable" mechanotransduction disorder. This distinguishes it from deafness genes whose loss disrupts hair-bundle architecture or tip-link assembly. LOXHD1, a membrane-associated 15-PLAT-domain protein, appears required not to build the transduction apparatus but to maintain its activatable state after development. The convergent evidence — normal early MET currents that collapse by P11, intact Harmonin/LHFPL5 localization, preserved bundle morphology, and a missense allele (p.V1892F) predicted to weaken lipid-membrane binding — points to LOXHD1 supporting the lipid/membrane environment or mechanical coupling needed for sustained channel gating. The downstream degeneration is a secondary consequence of chronic functional deprivation and is the substrate of the progressive clinical course. The recessive, LoF-tolerant population-genetic signature (LOEUF ≈ 0.93; pLI ≈ 0) is exactly what this two-hit disease biology predicts.

Feature	DFNB77 (LOXHD1)	Interpretation
Bundle development	Normal	Not a morphogenesis defect
Tip links / MET proteins	Present (Harmonin, LHFPL5)	Machinery assembled
MET current	Normal early → collapses ~P11	Post-developmental activation failure
Hair cells over time	Progressive degeneration	Basis of clinical progression
Vestibular function	Spared	Cochlea-selective phenotype
Constraint (gnomAD)	LoF-tolerant, pLI≈0	Consistent with recessive inheritance

Evidence Base

PMID	Title (abbrev.)	Role
19732867	Mutations in LOXHD1… disrupt hair cell function… progressive hearing loss	Foundational — gene discovery, PLAT/stereocilia localization, samba mouse, DFNB77 definition
33707295	Trouillet et al., J Neurosci (Loxhd1 MET function)	Core mechanism — post-developmental MET collapse; machinery present but not activatable
31547530	Mutational Spectrum and Clinical Features (Maekawa, Japan)	Phenotype/epidemiology — 28 patients, early onset, no vestibular signs, c.4212+1G>A founder
29676012	Wesdorp et al. (9 Dutch families)	Expressivity — variable phenotype, no genotype correlation, no FCD in carriers
26973026	Minami et al. (Japanese family, compound het)	Genotype–phenotype — milder high-freq loss; p.V1892F reduces lipid affinity
42131115	Zhang et al. (Chinese cohort)	Management — 10 variants; cochlear implant restores age-appropriate language
30139988	Danial-Farran et al. (consanguineous Arab families)	Recurrence — LOXHD1 among recessive deafness alleles
26561413	Atik et al. (Turkish ARNSHL panel)	Recurrence/diagnostics — NGS panel detection of LOXHD1
37441688	Systematic review — SLC4A11/ZEB1/LOXHD1/AGBL1 in FECD	Refutes/qualifies the LOXHD1–Fuchs corneal dystrophy association

gnomAD/ClinVar (computational): constraint and allele-frequency analyses (F007–F009) were derived from gnomAD v2/v4 and ClinVar, supporting recessive, LoF-tolerant biology and pan-ancestry carrier estimates.

Limitations and Knowledge Gaps

Prevalence is a lower bound. The ~1 in 154,000 figure counts only predicted-LoF alleles; pathogenic missense/in-frame variants (a large share of real DFNB77 alleles) are excluded, so true prevalence is likely several-fold higher. Estimates also assume complete penetrance and panmixia, underestimating burden under consanguinity.
Precise molecular function of LOXHD1 is unresolved. Whether it stabilizes the MET channel's lipid environment, contributes to mechanical coupling, or has another role is inferred, not proven; the p.V1892F lipid-affinity effect is computational (SWISS-MODEL).
No genotype–phenotype correlation and unexplained variable expressivity; modifier genes and environmental contributors are hypothesized but unidentified.
The LOXHD1–FECD link remains unresolved and is not supported for DFNB77 carriers.
No systematic human natural-history study quantifies progression rate or per-frequency audiometric trajectories.
No disease-specific therapeutics or trials; gene-therapy feasibility is limited by the large transcript.

Proposed Follow-up Experiments / Actions

Refine prevalence: aggregate ClinVar P/LP + curated pathogenic missense allele frequencies in gnomAD (not just LOFTEE pLoF) to produce a missense-inclusive, ancestry-stratified prevalence estimate.
Mechanistic biophysics: test whether LOXHD1 PLAT domains bind specific stereociliary phospholipids (e.g., PIP2) in vitro, and whether p.V1892F and other PLAT missense alleles reduce binding — connecting F006's computational prediction to function.
Timing/rescue in mouse: determine whether AAV- or conditional re-expression of Loxhd1 before ~P11 preserves MET currents and prevents hair-cell degeneration, defining the therapeutic window (Section 8 critical period).
Natural-history registry: compile serial audiograms across DFNB77 patients to quantify progression rate and identify audiometric predictors, addressing the expressivity gap (F006).
Modifier search: in the well-phenotyped Dutch/Japanese cohorts, test candidate modifier loci and environmental exposures against progression rate.
Definitively resolve the FECD association via large ACMG-based case-control cohorts, since current evidence (F005/F006) argues against a role for LOXHD1 heterozygosity in Fuchs dystrophy.

Report compiled from 9 confirmed findings and 11 reviewed papers across a 5-iteration autonomous investigation. Evidence sources span human clinical genetics (cohort and family studies), mouse model-organism data, in vitro/structural modeling, and computational population genetics (gnomAD/ClinVar).

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	9
Resolved	9
Unresolved (possible confabulation)	0
Unverifiable	0
References weighed for topical relevance	9
On topic	8
Off topic	0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome	Count
Terms checked	23
Resolved	20
Unresolved (possible confabulation)	1
Obsolete	0
Unverifiable	2
Terms whose name was checked	13
Terms named correctly	12
Terms named as a different term	0
Terms whose name is worth a second look	1

Unresolved terms

These identifiers do not exist in an ontology that resolved other terms from the same prefix, so they were most likely invented:

HP:0008550 (2 mentions), reported as "High-frequency hearing impairment" - HP does not contain this term

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

UBERON:0002227 (2 mentions) - the report calls it "cochlea"; UBERON calls it spiral organ of cochlea, and lists "cochlear spiral organ" among its other names

Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: ORPHA.

Ask OpenScientist

OpenScientist Report

Inheritance

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Progression

Prevalence

Animal Models

Source YAML

References & Deep Research

References

Deep Research

Key Findings

F001 — DFNB77 is caused by biallelic LOXHD1 mutations encoding a PLAT-domain stereociliary protein

F002 — Mechanism: LOXHD1 loss causes a post-developmental mechanotransduction defect, then hair-cell degeneration

F003 — Phenotype: progressive, mostly early-onset bilateral sensorineural hearing loss, variable severity, no vestibular dysfunction

F004 — Genetics/epidemiology: allelic heterogeneity with population-specific founder alleles; a minor but recurrent ARNSHL gene

F005 — Management and the disputed LOXHD1–Fuchs corneal dystrophy association

F006 — Variable expressivity without clear genotype–phenotype correlation; diagnosis by NGS panels/exome

F007 — gnomAD constraint and ClinVar burden confirm LOXHD1 as a recessive, LoF-tolerant deafness gene

F008 — gnomAD-derived estimate: pLoF carrier frequency ~0.5%, predicted biallelic-LoF prevalence ~6.5 per million (lower bound)

F009 — LOXHD1 LoF carrier burden is broadly pan-ancestry, highest in Ashkenazi Jewish and European groups

Full Section-by-Section Report

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic/Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome/Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Mechanistic Model / Interpretation

Evidence Base

Limitations and Knowledge Gaps

Proposed Follow-up Experiments / Actions

Artifacts

Reference Validation

Term Validation

Unresolved terms

Terms whose name is worth a second look

Prefixes with no resolver